EP2717967A2 - Körperpflegezusammensetzungen mit ph-abstimmbarem geliermittel und verwendungsverfahren - Google Patents

Körperpflegezusammensetzungen mit ph-abstimmbarem geliermittel und verwendungsverfahren

Info

Publication number
EP2717967A2
EP2717967A2 EP12730723.9A EP12730723A EP2717967A2 EP 2717967 A2 EP2717967 A2 EP 2717967A2 EP 12730723 A EP12730723 A EP 12730723A EP 2717967 A2 EP2717967 A2 EP 2717967A2
Authority
EP
European Patent Office
Prior art keywords
bis
azanediyl
diyl
diylbis
diisonicotinamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP12730723.9A
Other languages
English (en)
French (fr)
Inventor
Susana Fernandez Prieto
Johan Smets
Beatriu Escuder Gil
Juan Felipe Miravet Celades
Vicent Josep NEBOT CARDA
Paul Robert Tanner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of EP2717967A2 publication Critical patent/EP2717967A2/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/48—Thickener, Thickening system

Definitions

  • Personal care compositions comprising a pH tuneable gellant that is compatible with a broad range of personal care ingredients.
  • compositions include anti-aging lotions, after-shave balms, hair styling products, mascaras, and the like.
  • Structurants are typically selected based upon the particular phase being structured. Structurant selection may be limited if the composition includes reactive materials such as anionic species that can complex with cationic structurants. Structurant selection may be further limited given the pH of the personal care composition. Low or high pH can limit the efficacy of many structurants.
  • a sufficient amount of structurant is needed to achieve a consumer desireable and aesthetically pleasing viscosity. At efficacious levels, many structurants can result in an undesireable greasy or tacky skin feel. As a result, a challenge exits to find structurants compatible with a broad range of potential personal care compositions while providing consumer acceptable aesthetics.
  • compositions comprising a pH tuneable gellant.
  • the pH tuneable gellant has a formula of:
  • Ri and R2 are aminofunctional end-groups;
  • is a backbone moiety having molecular weight from 14 to 500 g/mol; and at least one of Li, R] or R2 comprises a pH-sensitive group;
  • R5 is an aminofunctional moiety
  • L2 is a backbone moiety having molecular weight from 14 to 500 g/mol
  • at least one of L ⁇ or R5 comprises a pH-sensitive group
  • the personal care composition may be a leave-on composition.
  • the personal care composition may be in the form of an emulsion comprising an aqueous phase, an oil phase, and a pH tuneable gellant as previously described.
  • a personal care composition may comprise a pH tuneable gellant, as previously described and an active or agent selected from a group consisting of sugar amines, vitamins, oil control agents, photosterols, hexamidine compounds, tightening agents, anti-wrinkle actives, anti- atrophy actives, flavonoids, N-acyl amino acid compounds, retinoids, peptides, particulate materials, UV actives,, photostabilizers, anti-cellulite agents, desquamation actives, anti-acne actives, anti-oxidants, radical scavengers, conditioning agents, anti-inflammatory agents, tanning actives, skin lightening agents, botanical extracts, antimicrobial actives, antifungal actives, antibacterial actives, antiperspirant actives, sensates, preservatives, anti-dandruff actives, substantivity polymers, detersive surfactants, and combinations thereof.
  • an active or agent selected from a group consisting of sugar amines, vitamins, oil control agents, photoste
  • compositions of the present invention can comprise, consist essentially of, or consist of, the essential components as well as optional ingredients described herein.
  • “consisting essentially of” means that the composition or component may include additional ingredients, but only if the additional ingredients do not materially alter the basic and novel characteristics of the claimed compositions or methods.
  • compositions suitable for topical application on keratinous tissue means compositions suitable for topical application on keratinous tissue.
  • applying or “application,” as used in reference to a composition means to apply or spread the compositions of the present invention onto keratinous tissue such as the epidermis.
  • keratinous tissue refers to keratin-containing layers disposed as the outermost protective covering of mammals (e.g., humans, dogs, cats, etc.) which includes, but is not limited to, skin, lips, hair, toenails, fingernails, cuticles, hooves, etc.
  • compositions or components described are suitable for use in contact with human skin tissue without undue toxicity, incompatibility, instability, allergic response, and the like.
  • safe and effective amount means an amount of a compound or composition sufficient to significantly induce a positive benefit.
  • leave-on means compositions applied to a keratinous tissue and are left on the keratinous tissue for at least 15 minutes. Leave-on compositions exclude rinse-off applications such as shampoos, facial cleansers, hand cleansers, body wash, or body cleanses.
  • the leave-on compositions of may be substantially free of cleansing or detersive surfactants.
  • leave-on compositions may comprise less than 1 % cleansing surfactants, less than 0.5% cleansing surfactants, or 0% cleansing surfactants.
  • the compositions may, however, contain emulsifying or other processing surfactants that are not intended to provide any significant cleansing benefits when applied topically to the skin.
  • derivatives means an ester, ether, amide, hydroxy, and/or salt structural analogue of the relevant compound.
  • to structure means to increase viscosity, thicken, solidify, or provide solid or crystalline structure to the personal care composition
  • soluble means at least about 0.1 g of solute dissolves in 100 ml of solvent, at 25 °C and 1 atm of pressure. pll tuneable gellant
  • the personal care composition includes a pH tuneable gellant.
  • the pH tuneable gellant may serve as a structurant in the personal care composition.
  • the personal care composition may comprise from about 0.001 %, 0.01 %, 0.05%, 0.1 %, 0.5%, 1 %, 2.5%, 5%, 7.5%, or 10% to about 30%, 25%, 20%, 15%, 10%, 5%, 3%, 2%, 1 %, or 0.5% of the pH tuneable gellant.
  • the pH tuneable gellant may be used in an aqueous phase including water and/or water-equivalent solvent.
  • the pH tuneable gellant may be used in an oil phase including oils described herein.
  • the pH tuneable amido gellant provides the personal care composition with a viscosity profile that is dependent on the pH of the composition.
  • the pH tuneable amido gellants comprise at least one pH sensitive group.
  • a pH tuneable amido gellant is added to a polar protic solvent such as water, it is believed that the nonionic species form the viscosity building network while the ionic species are soluble and do not form a viscosity building network.
  • the amido gellant is either protonated or deprotonated.
  • the solubility and the viscosity building behaviour of the amido gellant can be controlled.
  • the pH-sensitive groups the pKa of the amido gellant can be tailored. Therefore, the choice of the pH-sensitive groups can be used to select the pH at which the amido gellant builds viscosity.
  • the pH tuneable amido gellant has a formula selected from the group consisting of:
  • Ri and R2 are aminofunctional end-groups; Li is a backbone moiety having molecular weight from 14 to 500 g/mol; and at least one of Li, R
  • R5 is an aminofunctional moiety; is a backbone moiety having molecular weight from 14 to 500 g/mol ; and at least one of L 2 or R5 comprises a pH-sensitive group; and mixtures thereof; wherein the pH tuneable amido gellant has a pKa of from 1 to 30, or, alternately, a pKa of from 1.5 to 14.
  • Aminofunctional end-group and “aminofunctional moiety” are to be read as including amino and amido groups and may further include moities other than the amino and amido groups. Suitable aminofunctional end-groups and moities are exemplified in greater detail below.
  • the pH tuneable amido gellant comprises at least one amido functional group, and further comprises at least one pH-sensitive group.
  • the pH tuneable amido gellant may have a molecular weight from about 150 g/mol, 300 g/mol, or 400 g/mol to about 1500 g/mol, 900 g/mol, or 700 g/mol.
  • the pH tuneable amido gellant has the following structure [I]:
  • Li is a backbone moiety having molecular weight from 14 to 500 g/mol; and at least one of Li , R] or R 2 comprises a pH-sensitive group.
  • preferably has the formula:
  • (a+b+c+d) is from 1 to 20; and A, B, C and D are independently selected from the linking groups consisting of:
  • A, B, C and D are independently selected from the linking groups consisting of: H or R'
  • Li is selected from C2 to C20, C6 to C12, or C8 to CIO hydrocarbyl chains.
  • Ri is R3 or , R 2 is R 4 or , wherein each AA is inde endently selected from the group consisting of:
  • R3 and R4 independently have the formula:
  • (o + q) is from 1 to 10;
  • L' and L" are linking groups, independently selected from the same groups as A, B, C and D in equation [III]; and
  • R, R' and R" are independently selected either from the pH-sensitive-groups consisting of:
  • n and m are integers from 1 to 20
  • R comprises the pH-sensitive group.
  • R, R' and R" are independently selected from the group of pH-sensitive groups consisting of:
  • the pH tuneable amido gellant having structure [I] is characterized in that: Li is an aliphatic linking group with a backbone chain of from 2 to 20 carbon atoms [such as -((_3 ⁇ 4) ⁇ - wherein n is selected from 2 to 20], and both R ⁇ and R2 have the structure:
  • AA is referably selected from the group consisting of: or from the group consisting of:
  • two or more of Li , L' and L" are the same group.
  • the pH tuneable amido gellant molecule described in formula [I] can be symmetric with respect to the Li entity or can be asymmetric. Without intending to be bound by theory, it is believed that symmetric pH tuneable amido gellant molecules allow for more orderly structured networks to form, whereas compositions comprising one or more asymmetric pH tuneable amido gellant molecules may create disordered networks.
  • the pH tuneable amido gellant has the structure [II]:
  • R5 is an aminofunctional moiety
  • L2 is a backbone moiety having molecular weight from 14 to 500 g/mol
  • at least one of Li or R5 comprises a pH-sensitive group
  • L 2 may have the formula:
  • L2 may be selected from C2 to C20, C6 to C I 2, or C8 to C I O hydrocarbyl chains.
  • R5 may have the formula:
  • AA is independently selected from the same group of AA as for structure [I]; (e+f+g) is from 0 to 20 or from 1 to 3.
  • At least one of AA, R or R'" comprises a pH sensitive group.
  • R comprises the pH sensitive group.
  • the pH tuneable amido gellant having structure [ ⁇ ] is characterized in that: L 2 is an aliphatic linking group with a backbone chain of from 2 to 20 carbon atoms, preferably -(CH2) juxtapos-CH 3 wherein n is selected from 2 to 20, and R5 has the structure: wherein each AA is independently selected from the group consisting of:
  • R is selected from the pH-sensitive roups consisting of: or from the group:
  • Suitable pH tunable amido gellants may be selected from Tables 1 -3 as provided below.
  • Table 1 Non-limiting examples of pll tuneable amido gellants having structure [I] for use in a personal care composition
  • pH tuneable amido gellants having a terminal pyridine group may be particularly suitable for gelling neutral to basic systems (i.e. , pH of greater than about 6).
  • pH tuneable amido gellants having a terminal carboxylic acid group e.g. , dioic acid structures
  • pH tuneable amido gellants having a terminal imidazole group may be particularly suitable for gelling neutral to basic systems (i.e. , pH of greater than about 6).
  • AA comprises at least one of: Alanine, ⁇ -Alanine and substituted Alanines; Linear Amino-Alkyl Carboxylic Acid; Cyclic Amino-Alkyl Carboxylic Acid; Aminobenzoic Acid Derivatives; Aminobutyric Acid Derivatives; Arginine and Homologues; Asparagine; Asparlic Acid; p- Benzoyl-Phenylalanine; Biphenylalanine; Citrulline; Cyclopropylalanine; Cyclopentylalanine; Cyclohexylalanine; Cysteine, Cystine and Derivatives; Diaminobutyric Acid Derivatives; Diaminopropionic Acid; Glutamic Acid Derivatives; Glutamine; Glycine; Substituted Glycines; Histidine; Homoserine; Indole Derivatives; Isoleucine; Leucine
  • the pH tuneable amido gellant molecule may also comprise protective groups, preferably from 1 to 2 protective groups, preferably two protective groups.
  • protective groups are provided in "Protecting Groups", P. J. Kocienski, ISBN 3 13 135601 4, Georg Thieme Verlag, Stutgart; and "Protective Groups in Organic Chemistry", T.W. Greene, P.G.M. Wuts, ISBN 0-471 -62301 -6, John Wiley& Sons, Inc. New York.
  • the pH tuneable amido gellant may have a minimum gelling concentration (MGC) of from about 0.1 mg/mL or 0.5 mg/mL to about 100 mg/mL, 25 mg/mL, or l Omg/mL in the personal care composition, at the target pH of the composition, in accordance with the MGC Test Method.
  • MGC minimum gelling concentration
  • the MGC as used herein can be represented as mg/ml or as a wt %, where wt% is calculated as the MGC in mg/ml divided by 10. .
  • the MGC is at least 0.1 mg/mL, at least 0.3 mg/mL, at least 0.5 mg/mL, at least 1 .0 mg/mL, at least 2.0 mg/mL, at least 5.0 mg/mL of pH tunable amido gellant.
  • the personal care composition may comprise a mixture of two or more pH tuneable gellant structurants.
  • a mixture may include a pH tuneable gellant structurants which have differeing solubilites in the carrier or solvent to be structured.
  • the personal care composition may be a skin care, anti-perspirant, deodorant, cosmetic, and hair care product.
  • the personal care composition may be used as, for example, a moisturizer, conditioner, anti-aging compound, skin lightener, sunscreen, sunless tanner, shave preparation, lipstick, foundation, mascara, after-shave, and combinations thereof.
  • the composition is applied to the face, neck, hands, arms, and other typically exposed areas of the body.
  • the personal care composition may involve a wide variety of forms. Non-limiting examples include simple solutions (e.g. , water or oil based), dispersions, and emulsions.
  • the personal care composition may be substantially anhydrous. "Substantially anhydrous” means that the composition comprises no more than about 1 %, 0.5%, or, 0% water.
  • the personal care compositions may be fluid or solid (gels, sticks, flowable solids, amorphous materials).
  • the personal care composition is in the form of an emulsion. Emulsion may be generally classified as having a continuous aqueous phase (e.g. , oil-in-water and water- in-oil-in-water) or a continuous oil phase (e.g. , water-in-oil and oil-in-water-in-oil).
  • the personal care composition has a turbidity of from about 5 NTU to less than about 3000 NTU, 1000 NTU, 500 NTU, or 100 NTU.
  • the personal care composition may be in a form comprising at least one discrete, visually distinct first phase and at least one discrete, visually distinct second phase.
  • "visually distinct" means that the phases can be separately seen by the human eye as distinctly separate regions (i.e., not emulsions or dispersions of particles.
  • At least one phase forms a stable pattern, for example a continuous or discontinuous line, a spiral, a curve, or other geometric shape, within a transparent phase, where "within” means that one phase is substantially surrounded by the other phase the and does not contact the side of a container.
  • the phases may form a swirled pattern, wherein both phases alternately contact the side of a container and wherein the width of each of phase, when viewed through the side of a transparent container, is substantially constant, but may differ from each other.
  • the phases may form a marbled pattern, wherein the phases alternately contact the side of the container and wherein the width of the individual phases, when viewed through the side of a transparent container, may vary throughout the composition, in one embodiment, the first phase is a transparent, clear or translucent aqueous phase and the second phase is either an opaque white or a colored non-aqueous phase. In another alternative embodiment, at least one aqueous phase forms a pattern within a non-aqueous phase. It is recognized that the composition optionally may comprise a three or more visually distinct and stable phases. Discrete, visually distinct multi-phase compositions are described in U.S. Patent Application Publication Nos. 2007/0297996, 2004/0057920, and 2004/02191 19.
  • the personal care composition may comprise a one or more carriers.
  • Carriers may be selected for various stability, aesthetics, and/or compatability with other materials present in the personal care composition.
  • Suitable carriers include water and/or water-equivalent solvents.
  • the personal care composition may comprise from about 1 % to about 95 % by weight of water and/or water- equivalent solvent.
  • the composition may comprise from about 1 %, 3%, 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, or 90% to about 90%, 85%, 80%, 75%, 70%, 65%, 60%, 55%, 50%, 45%, 40%, 35%, 30%, 25%, 20%, 15%, 10%, or 5% water and/or a water-equivalent solvent.
  • Water-equivalent solvent refers to a compound which has a similar ability as water to solubilze a material.
  • Suitable Water-equivalent solvents include monohydric alcohols, dihydric alcohols, polyhydric alcohols, glycerol, glycols, polyalkylene glycols such as polyethylene glycol, and mixtures thereof.
  • Particularly suitable solvents include lower aliphatic alcohols such as ethanol, propanol, butanol, isopropanol; diols such as l ,2-propanediol, l ,3-propanediol, butanediol, pentanediol, hexanediol, heptanediol, decanediol; glycerin; water, and mixtures thereof.
  • the personal care composition comprises water, diols, glycerin, and combinations thereof.
  • Suitable carriers also include oils.
  • the personal care composition may comprise from about 1 % to about 95 % by weight of one or more oils.
  • the composition may comprise from about 1 %, 3%, 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, or 90% to about 90%, 85%, 80%, 75%, 70%, 65%, 60%, 55%, 50%, 45%, 40%, 35%, 30%, 25%, 20%, 15%, 10%, or 5% of one or more oils.
  • Oils may be used to solubilze, disperse, or carry materials that are not suitable for water or water-equivalent solvents.
  • Suitable oils include silicones, hydrocarbons, esters, fatty amides, ethers, and mixtures thereof. Oils may be fluid at room temperature. However, certain personal care product forms (i.e. , solid or sem- solid stick) may require non-fluid oils.
  • the oils may be volatile or nonvolatile. "Non-volatile” means a material that exhibit a vapor pressure of no more than about 0.2 mm Hg at 25°C at one atmosphere and/or a material that has a boiling point at one atmosphere of at least about 300°C. "Volatile” means that the material exhibits a vapor pressure of at least about 0.2 mm. of mercury at 20° C. Volatile oils may be used to provide a lighter feel when a heavy, greasy film is undesirable.
  • Suitable oils include volatile oils.
  • the volatile oils may have a viscosity ranging from about 0.5 to 5 centistokes 25°C.
  • Volatile oils may be used to promote more rapid drying of the skin care composition after it is applied to skin.
  • Nonvolatile oils are also suitable for use in the composition.
  • Nonvolatile oils are often used for emolliency and protective properties.
  • Nonvolatile oils preferably may have a viscosity ranging from about 5 to about 800,000 est or from about 20 to about 200,000 est.
  • Suitable silicone oils inlcude polysiloxanes may have a viscosity of from about 0.5 to about 1 ,000,000 centistokes at 25°C. Such polysiloxanes can be represented by the general chemical formula:
  • R is independently selected from hydrogen or Ci-30 straight or branched chain, saturated or unsaturated alkyl, phenyl or aryl, trialkylsiloxy; and x is an integer from 0 to about 10,000, chosen to achieve the desired molecular.
  • R is hydrogen, methyl, or ethyl.
  • Commercially available polysiloxanes include the polydimethylsiloxanes, which are also known as dimethicones, examples of which include the DM-Fluid series from Shin-Etsu, the Vicasil ® series sold by Momentive Performance Materials Inc., and the Dow Corning ® 200 series sold by Dow Corning Corporation.
  • suitable polydimethylsiloxanes include Dow Corning® 200 fluids (also sold as Xiameter ® PMX-200 Silicone Fluids) having viscosities of 0.65, 1 .5, 50, 100, 350, 10,000, 12,500 100,000, and 300,000 centistokes.
  • Suitable dimethicones include those represented by the chemical formula:
  • R and R are each independently hydrogen or Ci-30 straight or branched chain, saturated or unsaturated alkyl, aryl, or trialkylsiloxy; and x and y are each integers of 1 to 1 ,000,000 selected to achieve the desired molecular weight.
  • Suitable silicones include phenyl dimethicone (BotansilTM PD- 151 from Botanigenics, Inc.), diphenyl dimethicone (KF-53 and KF-54 from Shin-Etsu), phenyl trimethicone (556 Cosmetic Grade Fluid from Dow Corning), or trimethylsiloxyphenyl dimethicone (PDM-20, PDM-200, or PDM- 1000 from Wacker-Belsil).
  • alkyl dimethicones wherein at least R' is a fatty alkyl (e.g. , Cn-n)-
  • a suitable alkyl dimethicone is cetyl dimethicone, wherein R' is a straight CI 6 chain and R is methyl. Cetyl dimethicone, is available as s 2502 Cosmetic Fluid from Dow Corning or as Abil Wax 9801 or 9814 from Evonik Goldschmidt GmbH.
  • Cyclic silicones are one type of silicone oil that may be used in the composition. Such silicones have the general formula:
  • a mixture of cyclomethicones is used where n is 4, 5, and/or 6.
  • silicone oils suitable for use in the personal care compositon include polymers having the general formula:
  • G is hydrogen, phenyl, hydroxy, or C
  • R 2 is hydrogen, phenyl or aryl, or a saturated hydrocarbon radical, preferably an alkyl radical from about Ci to about C 20 , and A " is a halide ion.
  • An exemplary silicone polymer is trimethylsilylamodimethicone as shown in the following formula:
  • Another exemplary silicone polymer is represented by the general formula:
  • R 3 is a monovalent hydrocarbon radical from Ci to Cig, preferably an alkyl or alkenyl, such as methyl
  • R 4 is a hydrocarbon, preferably a C
  • Q " is a halide ion, preferably chloride
  • r is an average statistical value from 2 to 20, preferably from 2 to 8
  • s is an average statistical value from 20 to 200, preferably from 20 to 50.
  • a suitable polymer of this class is known as UCARE SILICONE ALE 56TM, available from Union Carbide.
  • Other suitable silicone materials are disclosed in US Patent Applciation Publicaiton No. 2007/0039 103 A 1.
  • Suitable hydrocarbon oils include straight or branched chain a!kanes and alkenes. The chain length may be selected based on desired functional characteristics such as volatility. Suitable hydrocarbon oils may have between 5-20 carbon atoms or, alternately, between 8- 16 carbon atoms. Suitable hydrocarbons include pentane, hexane, heptane, decane, dodecane, tetradecane, tridecane, and C 8 -2o isoparaffins as disclosed in U.S. Pat. Nos. 3,439,088 and 3,818, 105.
  • Suitable hydrocarbons include isooctane, isododecane, isohexadecane, isoeicosane by Permethyl Corporation under the tradename Permethyl®.
  • Suitable hydrocarbon oils may have greater than about 20 carbon atoms. Examples of such hydrocarbon oils include C24-28 olefins, C30-45 olefins, C20-40 isoparaffins, hydrogenated polyisobutene, polyisobutene, polydecene, hydrogenated polydecene, mineral oil, pentahydrosqualene, squalene, squalane, and mixtures thereof.
  • esters typically contained at least 10 carbon atoms. These esters include esters with hydrocarbyl chains derived from fatty acids or alcohols (e.g. , mono-esters, polyhydric alcohol esters, and di- and tri-carboxylic acid esters).
  • the hydrocarbyl radicals of the esters hereof may include or have covalently bonded thereto other compatible functionalities, such as amides and alkoxy moieties (e.g. , ethoxy or ether linkages, etc.).
  • esters include, but are not limited to, isopropyl isostearate, hexyl laurate, isohexyl laurate, isohexyl palmilate, isopropyl palmitate, decyl oleate, isodecyl oleate, hexadecyl stcarate, decyl stearatc, isopropyl isostearate, dihexyldecyl adipate, lauryl lactate, myristyl lactate, cetyl lactate, oleyl stearate, oleyl oleate, oleyl myristate, lauryl acetate, cetyl propionate, and oleyl adipate.
  • Other suitable esters are further described in the Personal Care Product Council's international Cosmetic Ingredient Dictionary and Handbook, Thirteenth Edition, 2010, under the functional category of "Esters.”
  • esters suitable lor use in the personal care composition include mono-carboxylic acid esters of the general formula R'COOR, wherein R' and R arc straight or branched chain, saturated or unsaturated alkyl, aryl, and wherein sum of carbon atoms in R' and R is at least 10,
  • a suitable monoester is alkyl benzoate such as C12- 15 alkyl benzoate.
  • esters suitable lor use in the personal care composition include di- and tri-alkyl and alkenyl esters of carboxylic acids, such as esters of C 4 to C 8 dicarboxylic acids (e.g. C ⁇ to C22 esters, preferably Ci to Ce, of succinic acid, glutaric acid, and adipic acid).
  • di- and tri- alkyl and alkenyl esters of carboxylic acids include isocetyl stearyol stearate, diisopropyl adipate, dibutyl adipate, and tristearyl citrate.
  • esters suitable for use in the personal care composition include those known as polyhydric alcohol esters.
  • Such polyhydric alcohol esters include alkylene glycol esters, such as ethylene glycol mono and di-fatty acid esters, diethylene glycol mono- and di-fatty acid esters, polyethylene glycol mono- and di-fatty acid esters, propylene glycol mono- and di-fatty acid esters, polypropylene glycol monooleate, polypropylene glycol 2000 monostearate, ethoxylated propylene glycol monostearate, glyceryl mono- and di-fatty acid esters, polyglycerol poly-fatty acid esters, ethoxylated glyceryl monostearate, 1 ,3-butylene glycol monostearate, 1 ,3-butylene glycol distearate, polyoxyethylene polyol fatty acid ester, sorbitan fatty acid esters, and polyoxy- ethylene sorbitan fatty acid esters.
  • esters suitable for use in the personal care composition include glycerides, including, but not limited to, mono-, di-, and tri-glycerides, preferably di- and tri-glycerides, more preferably triglycerides.
  • the glycerides are preferably the mono-, di-, and tri-esters of glycerol and long chain carboxylic acids, such as C10 to C22 carboxylic acids.
  • a variety of these types of materials can be obtained from vegetable and animal fats and oils, such as castor oil, safflower oil, cottonseed oil, com oil, olive oil, cod liver oil, almond oil, avocado oil, palm oil, sesame oil, sweet almond oil, apricot kernel oil, camelina sativa oil, rapeseed oil, tamanu seed oil, linseed oil, coconut oil, lanolin oil, soybean oil, and the like.
  • Synthetic oils include, but are not limited to, triolein and tristearin glyceryl dilaurate.
  • glyceryl esters of fatty acids include fatty acid mono-, di-, and triglycerides which are natural fats or oils that have been modified such as glyceryl stearate, diglyceryl diiosostearate, polyglyceryl-3 isostearate, polyglyceryl-4 isostearate, polyglyceryl-6 ricinoleate, glyceryl dioleate, glyceryl diisotearate, glyceryl tetraisostearate, glyceryl trioctanoate, diglyceryl distearate, glyceryl linoleate, glyceryl myristate, glyceryl isostearate, PEG castor oils, PEG glyceryl oleates, PEG glyceryl stearates, PEG glyceryl tallowates, and the like.
  • Suitable oils include fatty amides.
  • Fatty amides include compounds having an amide functional group while being liquid at 25 °C and insoluble in water.
  • the fatty amide may have the general formula: R 2 O
  • Rl is an optionally functionalized, aliphatic, cycloaliphatic or cyclic, saturated or unsaturated, monovalent hydrocarbon radical containing from 1 to 30 carbon atoms (alternately, from 1 to 22 carbon atoms);
  • R2, R3 and R4, which may be identical or different, are hydrogen or optionally functionalized, aliphatic, cycloaliphatic or cyclic, saturated or unsaturated, monovalent hydrocarbon radicals containing from 1 to 30 carbon atoms, preferably from 1 to 22 carbon atoms; r is 0 or 1 ; q is an integer from 0 to 2; and p equals 0 or 1.
  • Particular fatty amides include N-acetyl-N-butylaminopropionate, isopropyl N-lauroylsarcosinate, and N,N,-diethyltoluamide.
  • Other suitable fatty amides are disclosed in U.S. Patent No. 6,872,401.
  • Suitable oils include ethers.
  • Suitable ethers include saturated and unsaturated fatty ethers of a polyhydric alcohol, and alkoxylated derivatives thereof.
  • Exemplary ethers include C 4 _ 2o alkyl ethers of polypropylene glycols, and alkyl ethers. Suitable examples of these materials include PPG- 14 butyl ether, PPG- 15 stearyl ether, dioctyl ether, dodecyl octyl ether, and mixtures thereof.
  • the personal care composition may comprise an emulsifier.
  • An emulsifier is particularly suitable when the composition is in the form of an emulsion or if immiscible materials are being combined.
  • the skin care composition may comprise from about 0.05%, 0. 1 %, 0.2%, 0.3%, 0.5%, or 1 % to about 20%, 10%, 5%, 3%, 2%, or 1 % emulsifier.
  • Emulsifiers may be nonionic, anionic or cationic. Non-limiting examples of emulsi fiers are disclosed in U.S. Patent 3,755,560, U.S. Patent 4,421 ,769, and McCutcheon's, Emulsifiers and Detergents, 2010 Annual Ed., published by M. C.
  • Suitable emulsifiers are further described in the Personal Care Product Council's International Cosmetic Ingredient Dictionary and Handbook, Thirteenth Edition, 2006, under the functional category of "Surfactants - Emulsifying Agents.”
  • Suitable emulsifying ethers and esters include:
  • Ethers of polyglycols and of fatty alcohols - including saturated or unsaturated Cn-30 alcohols (e.g. , oleyl alcohol, cetyl alcohol, stearyl alcohol or behenyl alcohol) and polyglycols • comprising n number of oxyalkylene groups wherein n an integer from 1 to 200 or, alternately, from 2 to 30 (e.g. , 1 to 20 oxyelhylene groups).
  • Particular examples include compounds with the INCI names of steareth-n, beheneth-n or oleth-n.
  • Suitable examples include compounds having the INCI names steareth-8, steareth- 10, stearefh-16, steareth-20, cetcth- 10, laureth-4, laureth-3, trideceth-6, ceteareth-5, oleth- 10, and beneth- 10.
  • Esters of polyglycols and of fatly acids - including saturated or unsaturated C 12-30 fatty acids ⁇ e.g. , oleic acid, cetylic acid, stearic acid) and polyglycols comprising n number of oxyalkylene groups wherein n an integer from 1 to 200 or alternately, 1 to 50 (e.g. , 1 to 20 oxyethylene groups).
  • Particular examples include compounds with the INCI name PEG-rc stearate or PEG-n oleate).
  • Suitable examples include polyethylene glycol-8 monostearate, polyethylene glycol- 10, or polyethylene glycol- 12 distearate.
  • a suitable example includes polyoxyethylenaled (20 OE) methyl glucose distearate,
  • a suitable example includes polyglyceryl-3 cetyl ether, such as Chimexane NL from Chimex,
  • Esters of C12-30 fatty acids and of glycerol or of polyglycerol - including esters comprising from ! to 10 glycerol groups include hexa-glyceryl monosterate, diglyceryl distearate, telraglyceryl tristearate, decaglyceryl decastearate, diglyceryl monostearate, hexaglyceryl tristearate, decaglyceryl pentastearate, the ester of glycerol and of palmitic and stearic acids, and glyceryl mono- and dibehenate.
  • Ethers of oxyalkylene-modified C 12-30 alcohols and of glycerol or polyglycerol are Ethers of oxyalkylene-modified C 12-30 alcohols and of glycerol or polyglycerol.
  • Ethers of C 12-30 fatty alcohols comprising and of sucrose or of glucose - Suitable examples include compounds with the INCI names of C12- 18 alkylglucoside, C 12-20 alkylglucoside (e.g., Montanov L from Seppic), cetearyl glucoside (e.g. , a mixture with cetearyl alcohol under the reference Montanov 68 from Seppic), myristyl glucoside (e.g. , a mixture with myi istyl alcohol under the reference Montanov 14 from Seppic) or cetearyl glucoside (e.g. , Tegocare CG 90 from Evonik Goldschmidt),
  • Esters of sucrose and of C 12-30 fatty acids include sucrose distearate or sucrose tristearate, sucrose cocoate, sucrose dilaurale, sucrose distearate, sucrose hexaerucate, sucrose hexapalmitate, sucrose laurate, sucrose mortierellate, sucrose myristate, sucrose oleate, sucrose palmitate, sucrose pentaerucate, sucrose polybehenate, sucrose polycottonseedate, sucrose polylaurate, sucrose polylinoleate, sucrose polyoleate, sucrose polypalmaie, sucrose polysoyate, sucrose polystearate, sucrose ricinoleate, sucrose stearate, sucrose tetraisostearate, and sucrose trilaurate.
  • a suitable example includes the mixture of esters (mono- and polyesters) of stearic acid and of sucrose sold as Crodesta Fl 10 by Croda.
  • Esters of pentaerythritol and of C 12-30 fatly acids include pentaeryth itol tetraslearate.
  • Ethers of sorbitol and/or of sorbitan and of alkoxylated sorbitan- Suitable examples include sorbeth-8 beeswax or sorbeth-20 beeswax from Nikko Chemical.
  • Ethers of polyglycols and of cholesterol - Particular examples include choleth-3, choleth- 10 (such as Emalex CS- 10 from Nihon Emulsion Company), choleth- 15 (such as Emalex CS-15 from Nihon Emulsion Company) or choleth-20 (such as Emalex CS-20 from Nihon Emulsion Company).
  • Esters of C 12-30 fatty acids and of alkoxylated ethers of sorbitol and/or of Suitable cxemples include polysorbate-60, polysorbate-61 , sorbet -3 isoslearate, polyoxyethylenated 4 OE sorbitan monostearate, and polyoxyethylenated 20 OE sorbitan tristearate.
  • Linear or branched type silicone emulsifiers may also be used.
  • Particularly useful polyether modified silicones include KF-601 1 , KF-6012, KF-601 3, KF-6015, KF-6015, KF- 6017, KF-6043, KF-6028, and KF-6038 from Shin Etsu.
  • Also particularly useful are the polyglycerolated linear or branched siloxane emulsifiers including KF-6100, KF-6104, and KF- 6105 from Shin Etsu.
  • Exemplary materials include materials with the following International Nomenclature of Cosmetic Ingredients (1NCI) designations: Bis-Butyldimethicone Polyglyceryl- 3; Bis-PEG/PPG-14/14 Dimethicone; Bis-butyldimethicone Polyglyceryl-3; Bis-isobutyl PEG/PPG- 10/7 Dimethicone copolymer; Bis- PEG/PPG- 18/6 Dimethicone; Bis-PEG/PPG-20/20 Dimethicone; Bis-PEG/PPG- 16/16 PEG/PPG- 16/16 Dimethicone; Bis(PPG-7 Undeceneth-21 - Dimethicone; Cetyl Dimethicone PEG-7 Acetate; Cetyl PEG-8 Dimethicone; Cetyl PEG/PPG- 15/16 Butyl Ether Dimethicone; Cetyl PEG/PPG- 1 5/15 Butyl Ether Dimethicone; Cetyl PEG/PPG
  • Emulsifiers also include emulsifying silicone elastomers. Suitable emulsifying silicone elastomers may include at least one polyalkyl ether or polyglycerolated unit. These cross-linked elastomers may also be co-modified to include alkyl substiluents. Suitable formation techniques are described in U.S. Pat. Nos. 5,236,986; 5,412,004; 5,837,793; and 5,81 1 ,487.
  • Polyoxyalylenated emulsifying silicone elastomers that may be used in at least one embodiment of the invention include those sold by Shin-Etsu Silicones under the names KSG-21 , KSG-20, KSG-30, KSG-3 1 , KSG-32, KSG-33 ; KSG-210 (dimethicone/PEG- 10/ 15 crosspolymer dispersed in dimethicone); KSG-310 (PEG- 15 lauryl dimethicone crosspolymer); SG-320 (PEG- 15 lauryl dimethicone crosspolymer dispersed in isododecane); KSG-330 (PEG- 15 lauryl dimethicone crosspolymer dispersed in trielhylhexanoin), KSG-340 (PEG- 10 lauryl dimethicone crosspolymer and PEG- 15 lauryl dimethicone crosspolymer).
  • silicone emulsifying elastomers are supplied by Dow CorningTM, including PEG- 12 dimethicone crosspolymers (DC 9010 and 901 1).
  • suitable silicone emulsifiers sold by Dow Corning include DC9010 and DC901 1.
  • Polyglycerolated emulsifying silicone elastomers are disclosed in PCT/WO 2004/024798.
  • Such elastomers include Shin-Etsu's KSG series, such as KSG-710 (dimethicone/polyglycerin-3 crosspolymer dispersed in dimethicone); or lauryl dimethicone/polyglycerin-3 crosspolymer dispersed in a variety of solvent such as isododecane, dimethicone, triethylhexanoin, available as KSG-810, KSG-820, KSG-830, or KSG-840 from Shin-Etsu.
  • crosslinked silicone elastomer emulsifier is dimethicone/PEG- 10/ 15 crosspolymer, which provides excellent aesthetics due to its elastomeric backbone, but also excellent emulsification properties.
  • crosslinked organosiloxane emulsifiers include, but are not limited to dimethicone/dimethicone PEG/PPG 1 5 crosspolymer; dimethicone PEG- 10 crosspolymer; di methicone PEG- 10/1 5 crosspolymer; dimethicone PEG- 15 crosspolymer;- dimethicone polyglycerin-3 crosspolymer; dimethicone PPG-20 crosspolymer; lauryl dimethicone PEG- 15 crosspolymer; lauryl dimethicone polyglycerin-3 crosspolymer; PEG-8 dimethicone polysorbate-20 crosspolymer; PEG- 10 dimethicone/vinyl dimethicone crosspoly
  • silicone elastomers may be supplied pre-swollen with a solvent.
  • the weight percentages recited for emulsifier use i. e. , from about 0.05% to about 20%, from about 0.1 % to about 10%, from about 0.5% to about 5%, or from about 1 % to about 3% emulsifier
  • the weight percentages recited for emulsifier use are of the elastomer alone (i. e. , excluding the weight of the solvent).
  • the personal care composition may comprise structuring agent in addition to the pH tunable amido gellant described above.
  • Structuring agents may be used to increase viscosity, thicken, solidify, or provide solid or crystalline structure to the personal care composition.
  • Structuring agents are typically grouped based on solubil ity, dispersibility, or phase compatibility.
  • aqueous or water structuring agents include polymeric agents, natural or synthetic gums, polysaccharides, and the like.
  • the composition may comprises from about 0.0001 %, 0.001 %, 0.01 %, 0.05%, 0.1 %, 0.5%, 1 %, 2%, 3%, 5% to about 25%, 20%, 10%, 7%, 5%, 4%, or 2%, by weight of the composition, of one or more structuring agents.
  • Polysaccharides and gums may be suitable aqueous phase thickening agents.
  • examples of such polysaccharides and gums include naturally derived materials such as agar, agarose, alicaligenes polysaccharides, algin, alginic acid, acacia gum, amylopectin, chitin, dextran, cassia gum, cellulose gum, gelati n, gellan gum, hyaluronic acid, hydroxyethyl cellulose, methyl cellulose, ethyl cellulose, pectin, sclerotium gum, xanthan gum, pectin, trehelose, gelatin, ammonium alginate, calcium alginate, calcium carrageenan, carnitine, carrageenan, guar gum, guar hydroxypropyltrimonium chloride, hyaluroinic acid, hydroxypropyl chitosan, hydroxypropyl guar, karaya gum
  • Suitable polysaccharides include alkyl hydroxyalkyl cellulose ethers such as cetyl hydroxyethylcellulose, which is the ether of cetyl alcohol and hydroxyethylcellulose. This material is sold under the tradename Natrosol® Plus CS from Ashland Aqualon Functional Ingredients.
  • Other useful polysaccharides include scleroglucans comprising a linear chain of ( 1 -3) linked glucose units with a ( 1 -6) linked glucose every three units, a commercially available example of which is ClearogelTM CS 1 1 from M .M.P., Inc..
  • Suitable classes of polymeric structuring agents include but are not limited to carboxylic acid polymers, polyacrylamide polymers, sulfonated polymers, high molecular weight polyalkylglycols or polyglycerins, copolymers thereof, hydrophobically modified derivatives thereof, and mixtures thereof.
  • Carboxylic acid polymers include carbomers. These polymers are crosslinked compounds containing one or more monomers derived from acrylic acid, substituted acrylic acids, and salts and esters of these acrylic acids and the substituted acrylic acids, wherein the crosslinking agent contains two or more carbon-carbon double bonds and is derived from a polyhydric alcohol. Suitable materials includes include the Carbopol ® 900 series (e.g.
  • Other suitable carboxylic acid polymeric agents include copolymers of Cio-30 alkyl acrylates with one or more monomers of acrylic acid, methacrylic acid, or one of their short chain (i.e. , C
  • crosslinking agent is an allyl ether of sucrose or pentaerytritol.
  • copolymers are known as acrylates/Cio-30 alkyl acrylate crosspolymers and are commercially available as Carbopol ® 1342, Carbopol ® 1382, PEMULENTM TR- 1 , and PEMULENTM TR-2, from Noveon, Inc.
  • Sulfonated polymers include polymers and copolymers containing 2-acrylamido-2- melhylpropane sulfonic acid (i.e. , AMPS or acryloyldimethyl tauric acid) and salts thereof.
  • AMPS structurants include sodium acrylate/sodium acryloyldimethyl taurate copolymer available as SIMULGEL® EG and SIMULGEL® EPG or hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer available as SIMULGEL® NS, SIMULGEL ® FL, and SIMULGEL ® I-NS 100; which are available from Seppic Corporation (Fairfield, N.J.).
  • Another suitable sulfonated polymers is sodium polyacryloyldimethyl taurate available as Simulgel® 800 from Seppic Corporation (Fairfield, N.J.).
  • Other suitable sulfonated polymers include acrylamide/sodium acryloyldimethyltaurate/acrylic acid copolymer available as AcudyneTM SCP from Rohm and Haas Company, Inc.; acrylamide/sodium acryloyldimelhyllaurate copolymer available as Simulgel ® 600 from Seppic; ammonium acryloyldimethyltaurate/beheneth-25 methacrylate crosspolymer avilable as Aristoflex ® B LV from Clariant International Ltd.; ammonium acryloyl dimethyltaurate/carboxyethyl acrylate crosspolymer avilable as Aristoflex ® TAC from Clariant International Ltd.; ammonium acryloyldimelhyllaurate
  • Acrylamide polymers and copolymers include SEPIGEL® 305 from Seppic Corporation (Fairfield, N.J.), which is designated by the Personal Care Product Council's International Cosmetic Ingredient Dictionary and Handbook, Thirteenth Edition, 2010, as "polyacrylamide and isoparaffin and laureth-7.”
  • Other polyacrylamide polymers include multi-block copolymers of acrylamides and substituted acrylamides with acrylic acids and substituted acrylic acids.
  • Commercially available examples of these multi-block copolymers include HYPAN® SR 150H, SS500V, SS500 W, SSSA 100H, from Lipo Chemicals, Inc., (Patterson, N.J .).
  • High molecular weight polyalkylglycols or polyglycerins may be used as structuring agents.
  • Suitable materials include polyethylene glycols (PEG) derivatives and polypropylene glycols (PPG) derivatives with an n degree of polymerization, n may be from 50 to 200,000.
  • PEG polyethylene glycols
  • PPG polypropylene glycols
  • polyglycerins which are repeating glycerin moieties where the number of repeating moieties ranges from 15 to 200, preferably from about 20- 100.
  • suitable polyglycerins include those having the INCI names polyglycerin-20, polyglycerin-40, and the like.
  • oil structuring agents examples include silicone and organic based materials. Suitable ranges of oil structuring agents are from about 0.01 %, 0.05%, 0.1 % 0.5%, 1 %, 2.5%, 5%, or 10% to about 30%, 25%, 20%, 15%, 10%, or 5%.
  • Suitable oil phase structuring agents may be silicone based, such as silicone elastomers, silicone gums, silicone waxes, linear silicones having a degree of polymerization allowing the silicone to increase the viscosity of the oil phase. Examples of silicone structuring agents include, but are not limited to, silicone elastomers, silicone gums, and silicone waxes,
  • Silicone elastomers suitable for use in the compositions of the invention include those that are formed by addition reaction-curing, by reacting an SiH-containing diorganosiloxane and an organopolysiloxane having terminal olefinic unsaturation, or an alpha-omega diene hydrocarbon, in the presence of a platinum metal catalyst.
  • Such elastomers may also be formed by other reaction methods such as condensation-curing organopolysiloxane compositions in the presence of an organotin compound via a dehydrogenation reaction between hydroxyl-terminated diorganopolysiloxane and SiH-containing diorganopolysiloxane or alpha omega diene; or by condensation-curing organopolysiloxane compositions in the presence of an organotin compound or a titanate ester using a condensation reaction between an hydroxyl-terminated diorganopolysiloxane and a hyd olysable organosiloxane; peroxide- curing organopolysiloxane compositions which thermally cure in the presence of an organoperoxide catalyst.
  • Suitable silicone elastomers may be in the powder form, or dispersed or solubilized in solvents such as volatile or nonvolatile silicones, or silicone compatible vehicles such as paral ' finic hydrocarbons or esters.
  • silicone elastomer powders include vinyl dimethicone/methicone silesquioxane crosspolymers like KSP- 100, KSP- 101 , KSP- 102, KSP- 103, KSP- 104, KSP- 105, available from Shin-Etsu, hybrid silicone powders that contain a fluoroalkyl group like KSP-200, available from Shin-Etsu, which is a fluoro-silicone elastomer, and hybrid silicone powders that contain a phenyl group such as KSP-300, available from Shin- Etsu, which is a phenyl substituted silicone elastomer; and DC 9506 available from Dow Corning.
  • silicone elastomer dispersed in a silicone compatible vehicle examples include dimethicone/vinyl dimethicone crosspolymers supplied by a variety of suppliers including Dow Corning Corporation under the tradenames DC9040 or DC9041 , Momentive under the tradename SFE 839, or Shin-Etsu Silicones under the tradenames KSG- 15, 16, 18.
  • KSG- 15 has the INCI name cyclopentasiloxane (and) dimethicone/vinyl dimethicone crosspolymer.
  • KSG- 18 has the INCI name diphenylsiloxy phenyl trimethicone (and) dimethicone/phenyl vinyl dimethicone crossoplymer.
  • Silicone elastomers may also be purchased from Grant Industries under the Gransil trademark.
  • Other suitable silicone elastomers have long chain alkyl substitutions such as lauryl dimethicone/vinyl dimethicone crosspolymers supplied by Shin Etsu under the tradenames KSG-31 , KSG-32, KSG-41 , KSG-42, KSG-43, and KSG-44.
  • Silicone gums are another oil phase structuring agent.
  • the silicone gum typically has a viscosity ranging from about 500,000 to 100 million est at 25° C, from about 600,000 to 20 million, from about 600,000 to 12 million est.
  • the silicone gums that are used in the compositions include, but are not limited to, those of the general formula wherein:
  • Ri to R io are each independently hydrogen, an alkyl having 1 to 30 carbon atoms, aryl, or aralkyl ; and X is H, OH, or a C l -30 alkyl or vinyl, x, y, or z may be zero with the proviso that (x + y + z) > 1.
  • Such silicone gums may be purchased in pure form from a variety of silicone manufacturers including Wacker-Chemie or Dow Corning, and the like. Such silicone gums include those sold by Wacker-Belsil under the trade names CM3092, Wacker-Belsil 1000, or Wacker-Belsil DM 3096.
  • a silicone gum where X is OH, also referred to as dimethiconol, is available from Dow Corning Corporation under the trade name 1 - 1254 Fluid, 2-9023 Fluid, and 2-9026 Fluid.
  • the silicone gum may also be purchased in the form of a solution or dispersion in a silicone compatible vehicle such as volatile or nonvolatile silicone.
  • Such a mixture may be purchased from Barnet Silicones under the HL-88 tradename, having the INCI name dimethicone.
  • Another example is a mixture of dimethiconol and volatile or nonvolatile silicone available from the Dow Coming Corporation as tradename 1401 Fluid, 1403 Fluid, and 1501 Fluid.
  • silicone waxes may be referred to as alkyl silicone waxes which and are semi-solids or solids at room temperature.
  • alkyl silicone wax means a polydimethylsiloxane having a substituted long chain alkyl (such as C 16 to 30) that confers a semi-solid or solid property to the siioxane.
  • examples of such silicone waxes include stearyl dimethicone, which may be purchased from Evonik Goldschmidt GmbH under the tradename Abil Wax 9800 or from Dow Coming under the tradename 2503.
  • Another example is bis-stearyl dimethicone (which may be purchased from Gransil Industries under the tradename Gransil A- 1 8), behenyl dimethicone, or behenoxy dimethicone.
  • Suitable viscosity increasing agents include polyamides and polysilicone- polyamide copolymers.
  • Suitable polysilicone-polyamide copolymers are disclosed in U.S. Patent Application Publication No. 2004/0170586.
  • a specific example of such copolymers is nylon 61 1/dimethicone copolymers by Dow Corning under the tradename Dow Corning 2-8178.
  • polyamides such as those purchased from Arizona Chemical under the UniclearTM and Sylvaclear ® including Sylvaclear ® A200V or A2614V (INCI name: ethylenediamine/hydrogenated dimer dilinoleate copolymer/bis-di-C 14- l 8 alkyl amide); Sylvaclear ® AF 1900V and Sylvaclear ® PA 1200V (INCI name: Polyamide-3); Sylvaclear ® C75V (INCI name: bis-stearyl ethylenediamine/neopentyl glycol/stearyl hydrogenated dimer dilinoleate copolymer); Sylvaclear® PE400V (INCI name: Polyamide-6); Sylvaclear ® WF 1500V (INCI name: Polyamide-4); or UniclearTM 100 VG (INCI name: ethylenediamine/stearyl dimer dilinoleate copolymer; or ethylenediamine/
  • Oil phase structuring agent may be one or more natural or synthetic waxes such as animal, vegetable, or mineral waxes. Generally such waxes have a melting point ranging from about 25°C to 125°C, and alternatively from about 30°C to about 100° C.
  • Non-limiting examples of suitable waxes include silicone waxes, fatty esters, for example cetyl and/or stearyl esters, acacia, beeswax, ceresin, flower wax, citrus wax, carnauba wax, jojoba wax, japan wax, polyethylene, microcrystalline, rice bran, lanolin wax, mink, montan, bayberry, ouricury, ozokerite, palm kernel wax, paraffin, avocado wax, apple wax, shellac wax, clary wax, spent grain wax, candelilla, grape wax, polyalkylene glycol derivatives thereof (for example PEG6-20 beeswax, or PEG- 12 carnauba wax) and mixtures of any of the aforementioned waxes.
  • the wax is a polyethylene wax, and alternatively is a polyethylene wax having a melting point of less than 120°C, alternatively less than 95C, and alternatively less than 85°C.
  • Non-limiting examples of suitable silicone waxes are disclosed in U.S. patents 5,413,781 and 5,725,845, and further include alkylmethyl polysiloxanes, C I O - C60 alkyl dimethicones, and mixtures thereof.
  • the silicone wax may be a C16-C28 alkyl dimethicone wax.
  • Other suitable silicone waxes include, but are not limited to stearoxydimethicone, behenoxy dimethicone, stearyl dimethicone, cetearyl dimethicone, cetyl dimethicone, and mixtures thereof.
  • Other structuring agents are natural or synthetic montmorillonite minerals such as hectorite, bentonite, and quatemized derivatives thereof, which are obtained by reacting the minerals with a quaternary ammonium compound (e.g. , stearalkonium bentonite and stearalkonium hectorite).
  • a quaternary ammonium compound e.g. , stearalkonium bentonite and stearalkonium hectorite.
  • silicas, silicates, silica silylate, and alkali metal or alkaline earth metal derivatives thereof are generally found in the particulate form and include silica, silica silylate, magnesium aluminum silicate, and the like.
  • the personal care compositions may comprise one or more optional components to provide an efficacious and/or consumer desirable product.
  • the composition can include other actives or agents.
  • suitable optional actives and agents may include an active or agent selected from a group consisting of sugar amines, vitamins, oil control agents, photosterols, hexamidine compounds, tightening agents, anti-wrinkle actives, anti-atrophy acti ves, flavonoids, N-acyl amino acid compounds, retinoids, peptides, particulate materials, UV actives, photostabilizers, anti-cell ulite agents, desquamation actives, anti-acne actives, anti- oxidants, radical scavengers, conditioning agents, anti-inflammatory agents, tanning actives, skin lightening agents, botanical extracts, antimicrobial actives, antifungal actives, antibacterial actives, antiperspirant actives, sensates, preservatives, anti-dandruff actives, substantivity polymers, detersive sur
  • compositions of the present invention can comprise a sugar amine, which is also known as amino sugar.
  • Sugar amine compounds useful in the present invention can include those described in PCT Publication WO 02/076423 and U.S. Patent No. 6,159,485.
  • the composition may comprise from about 0.001 %, 0.01 %, 0.05%, 0.1 %, 0.5%, or 1 % to about 10%, 7, 5%, or 2% by weight of the composition, of one or more sugar amine.
  • Sugar amines can be synthetic or natural in origin and can be used as pure compounds or mixtures of compounds (e.g. , extracts from natural sources or mixtures of synthetic materials).
  • glucosamine is generally found in many shellfish and can also be derived from fungal sources.
  • sacchar amine includes isomers and tautomers of such and its salts (e.g. , HC1 salt) and is commercially available from Sigma Chemical Co.
  • sugar amines examples include glucosamine, N-acetyl glucosamine, mannosamine, N-acetyl mannosamine, galactosamine, N-acetyl galactosamine, their isomers (e.g. , stereoisomers), and their salts (e.g. , HC1 salt).
  • glucosamine particularly D-glucosamine and N-acetyl glucosamine, particularly N-acetyl-D- glucosamine.
  • the composition may comprise from about 0.001 %, 0.01 %, 0.05%, 0.1 %, 0.5%, or 1 % to about 10%, 7, 5%, or 2%, by weight of the composition, of one or more vitamins.
  • vitamins means vitamins, pro-vitamins, and their salts, isomers and derivatives.
  • Non-limiting examples of suitable vitamins include: vitamin B compounds (including B l compounds, B2 compounds, B3 compound, B5 compounds, such as panthenol or "pro-B5", pantothenic acid, pantothenyl; B6 compounds, such as pyroxidine, pyridoxal, pyridoxamine; carnitine, thiamine, riboflavin); vitamin A compounds, and all natural and/or synthetic analogs of Vitamin A, including retinoids, retinol, retinyl acetate, retinyl palmitate, retinoic acid, retinaldehyde, retinyl propionate, carotenoids (pro-vitamin A), and other compounds which possess the biological activity of Vitamin A; vitamin D compounds; vitamin K compounds; vitamin E compounds, or tocopherol, including tocopherol sorbate, tocopherol acetate, other esters of tocopherol and tocopheryl compounds; vitamin C compounds, including ascorbate, ascorbyl esters of
  • the personal care compositions comprise a vitamin B3 compound.
  • Vitamin B3 compounds are particularly useful for regulating skin conditions, as described in U.S. Patent No. 5,939,082.
  • the composition may comprise from about 0.001 %, 0.01%, 0.05%, 0. 1 %, 0.5%, or 1 % to about 50%, 20%, 10%, 7%, or 5%, by weight of the composition, of the vitamin B3 compound.
  • vitamin B3 comp nd means a compound having the formula:
  • R is - CONH2 (i.e. , niacinamide), - COOH (i.e., nicotinic acid) or - CH20H (i.e. , nicotinyl alcohol); derivatives thereof; and salts of any of the foregoing.
  • CONH2 i.e. , niacinamide
  • COOH i.e., nicotinic acid
  • CH20H i.e. , nicotinyl alcohol
  • Exemplary derivatives of the foregoing vitamin B3 compounds include nicotinic acid esters, including non-vasodilating esters of nicotinic acid (e.g, tocopherol nicotinate, myristyl nicotinate), nicotinyl amino acids, nicotinyl alcohol esters of cafboxylic acids, nicotinic acid N- oxide and niacinamide N-oxide.
  • non-vasodilating esters of nicotinic acid e.g, tocopherol nicotinate, myristyl nicotinate
  • nicotinyl amino acids e.g, nicotinyl amino acids
  • nicotinyl alcohol esters of cafboxylic acids nicotinic acid N- oxide and niacinamide N-oxide.
  • the personal care compositions may comprise one or more oil control agents for regulating the production of skin oil, sebum, or for improving the appearance of oily skin.
  • oil control agents include salicylic acid, dehydroacetic acid, benzoyl peroxide, vitamin 133 compounds, their isomers, esters, salts and derivatives, and mixtures thereof.
  • Dehydroacetic acid includes materials having the formula:
  • dehydroacetic acid 3-Acetyl-6-methyl-2H-pyran-2,4(3H)-dione and can be commercially purchased from Lonza.
  • Dermatologically acceptable salts include alkali metal salts, such as sodium and potassium; alkaline earth metal salts, such as calcium and magnesium; non-toxic heavy metal salts; ammonium salts; and trialkylammonium salts, such astrimethylammonium and triethylammonium.
  • alkali metal salts such as sodium and potassium
  • alkaline earth metal salts such as calcium and magnesium
  • non-toxic heavy metal salts such as ammonium salts
  • ammonium salts such astrimethylammonium and triethylammonium
  • sodium, potassium, and ammonium salts of dehydroacetic acid may be used.
  • Sodium dehydroacetate is available from Tri-K Industries, Inc., as Tristat SDHA. Derivatives of dehydroacetic acid incude, but are not limited to, any compounds wherein the CH 3 groups are individually or in combination replaced by amides, esters, amino groups, alkyls, and alcohol esters.
  • Tautomers of dehydroacetic acid are the isomers of dehydroacetic acid which can change into one another with great ease so that they ordinarily exist in equilibrium.
  • tautomers of dehydroacetic acid can be described as having the chemical formula CsHgC ⁇ and generally having the formula above.
  • oil control agents include materials capable of absorbing oils and sebum. Suitable oil absorbing materials include starch, calcium silicate, polyethylene, nylon, boran nitride, mica, clays such as bentonite, montmarrillonite and kaolin, zeolite, cyclodextrins, fumed silica, synthetic clays such as polymer powders including natural, synthetic, and semisynthetic cellulose, fluorocarbon resins, polypropylene, modified starches of cellulose acetate, particulate cross-linked hydrophobic acrylate or methacrylate copolymers and mixtures thereof.
  • Suitable oil absorbing materials include starch, calcium silicate, polyethylene, nylon, boran nitride, mica, clays such as bentonite, montmarrillonite and kaolin, zeolite, cyclodextrins, fumed silica, synthetic clays such as polymer powders including natural, synthetic, and semisynthetic cellulose, fluorocarbon resin
  • the personal care composition may comprise from about 0.001 %, 0.01 %, 0.05%, 0. 1 %, 0.5%, or 1 % to about 25%, 20%, 10%, 7%, 5%, or 3% by weight of the composition, of one or more oil control agents.
  • the personal care compositions may comprise a phytosterol.
  • one or more phytosterols can be selected from the group consisting of ⁇ -sitosterol, campesterol, brassicasterol, A5-avennasterol, lupenol, a-spinasterol, stigmasterol, their derivatives, analogs, and combinations thereof.
  • the phytosterol is selected from the group consisting of ⁇ -sitosterol, campesterol, brassicasterol, stigmasterol, their derivatives, and combinations thereof.
  • the phytosterol is stigmasterol.
  • Phytosterols can be synthetic or natural in origin and can be used as essentially pure compounds or mixtures of compounds (e.g. , extracts from natural sources). Phytosterols are generally found in the unsaponifiable portion of vegetable oils and fats and are available as free sterols, acetylated derivatives, sterol esters, ethoxylated or glycosidic derivatives. More preferably, the phytosterols are free sterols. As used herein, "phytosterol” includes isomers and tautomers of such and is commercially available from Aldrich Chemical Company, Sigma Chemical Company, and Cognis.
  • the composition may comprise from about 0.0001 %, 0.001 %, 0.01 %, 0.05%, 0. 1 %, 0.5%, or 1 % to about 25%, 20%, 10%, 7%, 5%, or 3%, by weight of the composition, of one or more phytosterol.
  • compositions may include hexamidine compounds, its salts, and derivatives.
  • hexamidine compound means a compound having the formula:
  • the composition may comprise from about 0.0001 %, 0.001 %, 0.01 %, 0.05%, 0. 1 %, 0.5%, or 1 % to about 25%, 20%, 10%, 7%, 5%,or 3%, by weight of the composition, of one or more hexamine compounds.
  • hexamidine derivatives include any isomers and tautomers of hexamidine compounds including but not limited to organic acids and mineral acids, for example sulfonic acid, carboxylic acid, etc.
  • the hexamidine compounds include hexamidine diisethionate, commercially available as Eleastab ⁇ HP100 from Laborato es Serobi unanimouss. 6. Tightening Agents
  • the personal care composition may comprise a tightening agent.
  • a tightening agent is a compound capable of having a tightening effect on keratinous tissues and, typically, on skin.
  • Suitable tightening agents may be chosen from plant or animal proteins and their hydrolysates such as maize, rye, wheat, buckwheat, sesame, spelt, pea, bean, lentil, soybean and lupin; polysaccharides of natural origin including (i) polyholosides, for example, in the form of starch derived especially from rice, maize, potato, cassava, peas, wheat, oats, etc.
  • carrageenans alginates, agars, gellans, cellulose polymers and pectins, advantageously as an aqueous dispersion of gel microparticles, and (ii) latices composed of shellac resin, gum sandarac, dammars, elemis, copals, cellulose compounds, and mixtures thereof; mixed silicates including phyllosilicates and in particular laponites; colloidal particles of inorganic fillers such as silica/alumina col loidal particles such as those sold under then tradename LUDOX ® by W.R.
  • the personal care composition may comprise from about 0.0001 %, 0.001 %, 0.01 %, 0.05%, 0.1 %, 0.5%, or 1 % to about 30%, 25%, 20%, 10%, 7%, 5%, or 3% by weight of the composition, of one or more tightening agent.
  • compositions of the present invention can comprise a one or more anti-wrinkle actives or anti-atrophy actives.
  • exemplary anti-wrinkle/anti-atrophy actives suitable for use in the compositions of the present invention include dialkanoyl hydroxyproline compounds, hydroxy acids (e.g. , glycolic acid, lactic acid, lactobionic acid), keto acids (e.g., pyruvic acid), phytic acid, lysophosphatidic acid, stilbenes, cinnamates, resveratrol, kinetin, zeatin, dimethylaminoethanol, peptides from natural sources (e.g. , soy peptides), and salts of sugar acids (e.g.
  • the composition may comprise from about 0.0001 %, 0.001 %, 0.01 %, 0.05%, 0. 1 %, 0.5%, or 1 % to about 30%, 25%,20%, 10%, 7%, 5%, or 3% by weight of the composition, of one or more anti-wrinkle/anti-atrophy compounds.
  • Suitable dialkanoyl hydroxyproline compounds of the present invention can include those corresponding to the following chemical formula:
  • R is H, X, C1-C20 straight or branched alkyl
  • X is metals (Na, K, Li, Mg, Ca) or amines (DEA, TEA);
  • R 2 is C1-C20 straight or branched alkyl
  • R 3 is C]-C2o straight or branched alkyl.
  • Suitable derivatives include but are not limited to esters, for example fatty esters, including, but not limited to tripalmitoyl hydroxyproline and dipalmityl acetyl hydroxyproline.
  • a particularly useful compound is dipalmitoyl hydroxyproline.
  • dipalmitoyl hydroxyproline includes any isomers and tautomers of such and is commercially available under the tradename Sepilift DPHP® from Seppic, Inc. Further discussion of dipalmitoyl hydroxyproline appears in PCT Publication WO 93/23028.
  • the dipalmitoyl hydroxyproline is the triethanolamine salt of dipalmitoyl hydroxyproline as discussed in U.S. Patent No. 7,285,570. 8. F!avonoids
  • compositions of the present invention can comprise a flavonoid compound.
  • Flavonoids are broadly disclosed in U.S. Patents 5,686,082 and 5,686,367.
  • Examples of flavonoids particularly suitable for use in the present invention are one or more flavones, one or more isoflavones, one or more coumarins, one or more chromones, one or more dicoumarols, one or more chromanones, one or more chromanols, isomers (e.g. , cis/trans isomers) thereof, and mixtures thereof.
  • flavones and isoflavones are preferred for use herein, in particular daidzein (7,4 - dihydroxy isoflavone), genistein (5,7,4'-trihydroxy isoflavone), equol (7,4'-dihydroxy isoflavan), 5,7-dihydroxy-4'-methoxy isoflavone, soy isoflavones (a mixture extracted from soy) and other plant sources of such mixtures ⁇ e.g. , red clover), and mixtures thereof.
  • favanones such as hesperitin, hesperidin, and mixtures thereof.
  • Flavonoid compounds useful herein are commercially available from a number of sources, e.g. , Indofine Chemical Company, Inc., Steraloids, Inc., and Aldrich Chemical Company, Inc.
  • the composition may comprise from about 0.0001 %, 0.001 %, 0.01 %,
  • the topical compositions of the present invention can comprise one or more N-acyl amino acid compounds.
  • the amino acid can be one of any of the amino acids known in the art.
  • the N-acyl amino acid compounds of the present invention can correspond to the formula:
  • R can be a hydrogen, alkyl (substituted or unsubstituted, branched or straight chain), or a combination of alkyl and aromatic groups.
  • R 1 can be Cj to C30, saturated or unsaturated, straight or branched, substituted or unsubstituted alkyls; substituted or unsubstituted aromatic groups; or mixtures thereof.
  • the N-acyl amino acid compound may be selected from the group consisting of N-acyl Phenylalanine, N-acyl Tyrosine, their isomers, their salts, and derivatives thereof.
  • the amino acid can be the D or L isomer or a mixture thereof.
  • N-acyl Phenylalanine corresponds to the following formula:
  • R 1 can be Ci to C30 , saturated or unsaturated, straight or branched, substituted unsubstituted alkyls; substituted or unsubstituted aromatic groups; or mixtures thereof.
  • N-acyl Tyrosine corresponds to the following formula:
  • R 1 can be C ⁇ to C30 , saturated or unsaturated, straight or branched, substituted or unsubstituted alkyls; substituted or unsubstituted aromatic groups; or mixtures thereof.
  • N-undecylenoyl-L-phenylalanine Particularly useful as a topical skin tone evening cosmetic agent is N-undecylenoyl-L- phenylalanine.
  • This agent belongs to the broad class of N-acyl Phenylalanine derivatives, with its acyl group being a C l l mono-unsaturated fatty acid moiety and the amino acid being the L- isomer of phenylalanine.
  • N-undecylenoyl-L-phenylalanine corresponds to the following formula: O H
  • N-undecylenoyl-L-phenylalanine is commercially available under the tradename Sepiwhitc ⁇ from SEPPIC.
  • the composition may comprise from about 0.0001 %, 0.001 , 0.01 %,
  • composition 0.05%, 0.1 %, 0.5%, or 1 % to about 30%, 25%, 20%, 10%, 7%, 5%, or 3%, by weight of the composition, of one or more N-acyl amino acids.
  • the personal care compositions may comprise one or more retinoid.
  • the composition may comprise from about 0.0001 %, 0.001 %, 0.01 %, 0.05%, 0.1 %, 0.5%, or 1 % to about 30%, 25%, 20%, 10%, 7%, 5%, or 3%, by weight of the composition, of one or more retinoids.
  • concentration used in a composition will depend on the specific retinoid selected since their potency can vary considerably.
  • retinoid includes all natural and/or synthetic analogs of Vitamin A or retinol-like compounds which possess the biological activity of Vitamin A in the skin as well as the geometric isomers and stereoisomers of these compounds.
  • the retinoid may be selected from retinol, retinol esters (e.g. , C2 - C22 alkyl esters of retinol, including retinyl palmitate, retinyl acetate, retinyl propionate), retinal, and/or retinoic acid (including all-trans retinoic acid and/or 13-cis-retinoic acid), or mixtures thereof.
  • retinoids which are described in U.S. Patent Nos.
  • Suitable retinoids may include tocopheryl-retinoate [ tocopherol ester of retinoic acid (trans- or cis-), adapalene (6- [3-( l -adamantyl)-4-methoxyphenyl]-2-naphthoic acid ⁇ , and tazarotene (ethyl 6-[2-(4,4- dimethylthiochroman-6-yl)-ethynyl]nicotinate).
  • Suitable retinoids include retinol, retinyl palmitate, retinyl acetate, retinyl propionate, retinal and combinations thereof.
  • retinyl propionate may be used in amounts from about 0.1 % to about 0.3%.
  • the personal care composition may comprise a peptide.
  • Suitable peptides can include, but are not l imited to, cli-, tri-, tetra-, penta-, and hexa-peptides and derivatives thereof.
  • the compositions comprise from about l x l0 ⁇ 7 % to about 20%, from about lx l0 "6 % to about 10%, or from about lx l0 ⁇ 5 % to about 5%, by weight of a peptide.
  • the composition may comprise from about 0.0001 %, 0.001 %, 0.01 %, 0.05%, 0.1 %, 0.5%, or 1 % to about 25%, 20%, 1 0%, 7%, 5%, 3%, by weight of the composition, of one or more peptides.
  • peptide refers to pept ides containing ten or fewer amino acids and their derivatives, isomers, and complexes with other species such as metal ions (e.g. , copper, zinc, manganese, magnesium, and the like).
  • Peptide refers to both naturally occurring and synthesized peptides. Also useful herein are naturally occurring and commercially available compositions that contain peptides.
  • the peptides may contain at least one basic amino acid (e.g. , histidine, lysine, arginine).
  • suitable peptides are the dipeptide carnosine (beta-ala-his), the tripeptide gly-his-lys, the tripeptide his-gly-gly, the tripeptide gly-gly-his, the tripeptide gly-his- gly, the tetrapeptide gly-gln-pro-arg, the pentapeptide lys-thr-thr-lys-ser, lipophilic derivatives of peptides, and metal complexes of the aforementioned (e.g. , copper complex of the tripeptide his- gly-gly (also known as Iamin)).
  • dipeptide carnosine beta-ala-his
  • the tripeptide gly-his-lys the tripeptide his-gly-gly
  • the tripeptide gly-gly-his-his the tripeptide gly-his- gly
  • Suitable peptides include Peptide CK (arg-lys-arg); Peptide CK+ (ac-arg-lys-arg-NH2); and Peptide E, arg-ser-arg-lys.
  • a commercially available tripeptide derivative-containing composition is Biopeptide CL ® (from Sederma, France), which contains 100 ppm of palmitoyl-gly-his-lys and is commercially available.
  • a commercially available pentapeptide derivative-containing composition is atrixyl® (from Sederma, France), which contains 100 ppm of palmitoyl-lys-thr-thr-lys-ser.
  • a suitable peptide is a dipeptide based molecule having a C terminal amino acid of threonine, such as plamitoyl-lys-fhr, as described in US Patent Application Publication 2007/0020220 A 1 .
  • Peptide derivatives useful herein include lipophilic derivatives such as palmitoyl derivatives.
  • the peptide is selected from palmitoyl-lys-thr-thr-lys-ser, palmitoyl-gly-his-lys, their derivatives, and combinations thereof.
  • compositions of the present invention can comprise one or more particulate materials.
  • particulate materials useful in the present invention include colored and uncolored pigments, interference pigments, inorganic powders, organic powders, composite powders, optical brightener particles, and combinations thereof. These particulates can, for instance, be platelet shaped, spherical, elongated or needle-shaped, or irregularly shaped, surface coated or uncoated, porous or non-porous, charged or uncharged, and can be added to the current compositions as a powder or as a pre-dispersion.
  • the composition may comprise from about 0.0001 %, 0.001 %, 0.01 %, 0.05%, 0.1 %, 0.5%, 1 %, or 2% to about 50%, 25%, 20%, 10%, 7%, 5%, or 3% by weight of the composition, of particulate(s).
  • the pigment, colorant or filler powders used in the composition.
  • Particulate materials useful herein can include, but are not limited to, bismuth oxychloride, sericite, mica, mica treated with barium sulfate or other materials, zeolite, kaolin, silica, boron nitride, lauroyl lysine, nylon, polyethylene, talc, styrene, polypropylene, polystyrene, ethylene/acrylic acid copolymer, polyurethane, aluminum oxide, silicone resin, barium sulfate, calcium carbonate, cellulose acetate, PTFE, polymethyl methacrylate, starch, modified starches such as aluminum starch octenyl succinate, silk, glass, and mixtures thereof.
  • particulates include, but are not limited, to polymeric particles chosen from the polymcthylsilsesquioxane resin microspheres such as including materials sold under the tradename Tospearl ® by Momentive Performance Materials Inc., microspheres of polymethylmethacrylates such Micropearl M305 by SEPPIC, spherical particles of crosslinked polydimethylsiloxanes, especially such as those sold by Dow Corning 9506 Cosmetic Power by Dow Corning, spherical particles of polyamide and more specifically Nylon 12 such as Orgasol 2002 line by Atochem, polystyerene microspheres such as for example those sold under the name Dynospheres ® by Dyno Particles, ethylene acrylate copolymer sold under the name EA209 by Kobo, PTFE, polypropylene, aluminum starch ocetenylsuccinate such as those sold under the name Dry-Flo ® by AkzoNobel, microspheres of polyethylene such as those
  • Interference pigments are defined as thin platelike layered particles having two or more layers of controlled thickness with different refractive indices that yield a characteristic reflected color from the interference of typically two, but occasionally more, light reflections, from different layers of the platelike particle.
  • the most common examples of interference pigments are micas layered with about 50 - 300 nm films of Ti02, Fe203, silica, tin oxide, and/or Cr203. Such pigments are often pearlescent. Pearl pigments reflect, refract and transmit light because of the transparency of pigment particles and the large difference in the refractive index of mica platelets and, for example, the titanium dioxide coating.
  • interference pigments are available commercially from a wide variety of suppliers, for example, Rona (TimironTM and DichronaTM ), Presperse (FlonacTM ), Englehard (DuochromeTM ), Kobo (KTZ Interfine and KTZ Interval), BASF (Ref!ecksTM) and Eckart (Prestige series).
  • Suitable interference pigments may have a small particle sizes, with an average diameter of individual particles less than about 75 microns in the longest direction, or less than about 50 microns.
  • Suitbale pigments include inorganic pigments, organic pigments and combinations thereof.
  • useful inorganic pigments include iron oxides, ferric ammonium ferrocyanide, manganese violet, ultramarine blue, and Chrome oxide.
  • Organic pigments can include natural colorants and synthetic monomeric and polymeric colorants. An example is phthalocyanine blue and green pigment. Also useful are lakes, primary FD&C or D&C lakes and blends thereof. Also useful are encapsulated soluble or insoluble dyes and other colorants.
  • Inorganic white or uncolored pigments useful in the present invention for example Ti02, ZnO, or Zr02, are commercially available from a number of sources.
  • Suitable particulate material contains the material available from U.S. Cosmetics (TRONOX Ti02 series, SAT-T CR837, a rutile Ti02).
  • Suitable pigments include charged dispersions of titanium dioxide, as are disclosed in U.S. Patent No. 5,997,887.
  • Colored or uncolored pigments may have a primary average particle size of from about 10 nm, 15 nm, or 20 nm to about 100,000 nm, 5,000nm, or lOOOnm. Mixtures of the same or different pigments having different particle sizes are also useful herein (e.g. , incorporating a T1O2 having a primary particle size of from about 100 nm to about 400 nm with a T1O 2 having a primary particle size of from about 10 nm to about 50 nm).
  • the particulate materials can be surface treated to provide added stability and/or for ease of formulation.
  • suitable coating materials include silicones, lecithin, amino acids, metal soaps, polyethylene and collagen. These surface treatments may be hydrophobic or hydrophilic. Particularly useful hydrophobic pigment treatments include polysiloxane treatments such as those disclosed in U.S. Patent 5, 143,722.
  • compositions of the subject invention may optionally contain a UV active.
  • UV active includes both sunscreen agents and physical sunblocks. Suitable UV actives may be organic or inorganic. Suitable UV actives are listed in the functional category of "Sunscreen Agents" in the Personal Care Product Council's International Cosmetic Ingredient Dictionary and Handbook, Thirteenth Edition, 2010.
  • Suitable UV actives include dibenzoylmethane derivatives including 2- methyldibenzoylmethane, 4-methyldibenzoylmethane, 4-isopropyldibenzoylmethane, 4-tert- butyldibenzoylmethane, 2,4- dimethyldibenzoylmethane, 2,5- dimethyldibenzoylmethane, 4,4'- diisopropyldibenzoylmethane, 4,4'-dimethoxy dibenzoylmethane, 4-tert-butyl-4'-methoxy dibenzoylmethane (i.e., butyl methoxydibenzoylmethane or avobenzone)(commercially available as PARSOL ® 1789 from DSM), 2-methyl-5-isopropyl-4'-methoxy dibenzoylmethane, 2-methyl- 5-tert-butyl-4'-methoxydibenzoylme
  • UV actives include 2- ethylhexyl-p-methoxycinnamate (commercially available as PARSOL ® MCX from DSM), 2- hydroxy-4-methoxybenzophenone, benzonphenone-3 (i.e.
  • octyldimethyl-p- aminobenzoic acid digalloyltrioleate, 2,2-dihydroxy-4-methoxybenzophenone, ethyl-4- (bis(hydroxy-propyl))aminobenzoate, 2-ethylhexyl-2-cyano-3,3-diphenylacrylate, 2-cthylhexyl- salicylate, glyceryl-p-aminobenzoate, 3,3,5-tri-methylcyclohexylsalicylate, methylanthranilate, p- dimethyl-aminobenzoic acid or aminobenzoate, 2-ethylhexyl-p-dimethyl-amino-benzoate, 2- phenylbenzimidazole-5-sulfonic acid, 2-(p-dimethylaminophenyl)-5-sulfonicbenzoxazoic acid, octocrylene, zinc oxide, titanium
  • UV actives useful in the compositions of the present invention are 2- ethylhexyl-p-methoxycinnamate, 4-tert-butyl-4'-methoxy dibenzoylmethane, 2-hydroxy-4- mcthoxybenzo-phenone, 2-phenylbenzimidazole-5-sulfonic acid, octocrylene, zinc oxide, titanium dioxide, and mixtures thereof.
  • UV actives include 4-methylbenzylidene camphor (commercially available as PARSOL ® 5000 from DSM or Eusolex 6300 from Merck), methylene bis-benzotriazolyl tetramethylbutylphenol (i.e. , bisoctrizole, commercially available as Tinosorb ® M from BASF), bis-ethylhexyloxyphcnol methoxyphenol triazine (i.e. , bemotrizinol,commercially available as Tinosorb ® S from BASF), disodium phenyl dibenzimidazole tetrasulfonate (i.e.
  • Iscotrizinol commercially available as Uvasorb® HEB by 3V Sigma
  • Polysilicone- 15 i. e. , commercially available as PARSOL® SLX from DSM
  • Isoamyl p-Methoxycinnamate i.e. , amiloxate, commercially available as Neo Heliopan ® E 1000 from Symrise.
  • a suitable photostabil izer is alpha-cyanodiphenylacrylate is as disclosed in U.S. Patent No. 7,713,519.
  • the alpha-cyanodiphenylacrylate may have the general formula:
  • R l and R2 are each independently straight or branched chain C I -30 alkoxy; any non- alkoxy R l or R2 radical is hydrogen; and R3 is a straight or branched chain C l -30 alkyl.
  • R l and R2 are each independently Cl -8, and any non-alkoxy radical R l or R2 is hydrogen; and R3 is a straight of branched chain C2-20 alkyl.
  • R l and R2 are each independently methoxy, and any non-methoxy Rl or R2 is hydrogen; and R3 is a straight or branched chain C2-20 alkyl.
  • a suitable alpha-cyanodiphenylacrylate is ethylhexyl melhoxycrylene, or 2-ethylhexyl 2- cyano-3-(4-methoxyphenyl)-3-phenylpropenoate, wherein R l is methoxy, R2 is hydrogen, and R3 is 2-ethylhexyl.
  • This material is available from Hallstar Company under trade name Solastay® S l .
  • Another suitable suitable photostabilizer includes diesters or polyesters of naphthalene dicarboxylic acid as disclosed in U.S. Patent Nos. 5,993,789, 6, 1 13,931 , 6, 126,925 and 6,284,916.
  • Suitable diesters or polyesters of naphthalene dicarboxylic acid may have the following formula:
  • each R 1 independently is an alkyl group having 1 to 22 carbon atoms, or a diol having the formula HO-R 2 -OH, or a polyglycol having the formula HO-R 3 -(-0-R 2 -) m -OH, and, wherein R 2 and R 3 , same or different, are each an alkylene group, straight chain or branched, having 1 to 6 carbon atoms, wherein m and n are each 1 to about 100, 1 to about 10, or 2 to about 7.
  • a suitable diesters of naphthalene dicarboxylic acid is diethylhexyl 2,6-naphlhalate available as Corapan® TQ from Symrise.
  • Another suitable photostabilizer is 4-hydroxybenzylidenemalonate derivatives or 4- hydroxycinnamatc derivatives.
  • Suitable materials ma have the following formula:
  • R' is hydrogen, a linear or branched Ci-Cs alkyl radical or a linear or branched Ci-C 8 alkoxy radical; and
  • R" is a linear or branched Ci -Cs alkyl radical.
  • Exemplary compounds include ethyl-alpha- cyano-3,5-dimethoxy-4-hydroxy cinnamate, ethyl-alpha-acetyl-3,5-dimethoxy-4-hydroxy cinnamate, iso-propyl-alpha-acetyl-3,5-dimethoxy-4-hydroxy cinnamate, iso-amyl-alpha-acetyl- 3,5-dimethoxy-4-hydroxy cinnamate, 2-ethylhexyl-alpha-acetyl-3,5-dimethoxy-4-hydroxy cinnamate, diethyl-3,5-dimethoxy-4-hydroxy benzylidene malonate, di-(2-ethylhexyl)-3,5- dimethoxy-4-hydroxy benzylidene malonate, diisoamyl-3,5-dimethoxy-4-hydroxy benzylidene malonate, didodecyl-3,5-
  • Suitable photostabilizer is a 2-pyrrolidinone-4-carboxy ester compounds.
  • Suitable 2-pyrrolidinone-4-carboxy ester compounds may have the following formula:
  • R 1 is a linear or branched Ci-C ⁇ o alkyl radical
  • R 2 is a linear or branched C 1 -C 2 0 alkyl radical which can contain a Cs-C , ring, the phenyl radical, the benzyl radical or the phenethyl radical.
  • Exemplary radicals for R 1 and R 2 include methyl, ethyl, n-propyl, isopropyl, n- butyl, isobutyl, tert-butyl, n-octyl, 2-ethylhexyl, dodecyl, hexadecyl, cyclohexyl and methylcyclohexyl radicals.
  • 2-pyrrolidinone-4-carboxy ester compounds are provided in U.S. Patent Application Publication No. 2010/0183529.
  • photostabilizers include:
  • photostabilizers are listed in the functional category of "Light Stabilizers" in the Personal Care Product Council's International Cosmetic Ingredient Dictionary and Handbook, Thirteenth Edition, 2010.
  • the composition may comprise from about 0.0001 %, 0.001 %, 0.01 %, 0.05%, 0.1 %, 0.5%, or 1 % to about 30%, 25%, 20%, 10%, 7%, or 5%, by weight of the composition, of one or more suitable photostabilizer.
  • the personal care composition may comprise at: least one photostabilzer and at least one UV active.
  • the UV active is a dibenzoylmethane derivative.
  • the UV active is 4,4'-t-butyl methoxydibenzoyl-methane (i.e., avobenzone).
  • compositions of the present invention may also comprise an anti-ccllulite agent.
  • Suitable agents may include, but are not limited to, xanthine compounds (e.g. , caffeine, theophylline, theobromine, aminophylline, chloroethyltheophylline, dyphylline, etamiphylline, proxyphylline, and the like); extracts of tea, coffee, guarana, mate, cola (Cola nitidci); extracts of climbing ivy (Hedera helix), arnica (Arnica inonlana L), rosemary (Rosmarinus officinalis N), of marigold (Calendula officinalis), sage (Salvia officinalis L), ginseng (Panax ginseng), St.
  • xanthine compounds e.g. , caffeine, theophylline, theobromine, aminophylline, chloroethyltheophylline
  • John's wort Hypericum perforatum
  • butcher's broom Ruscus aculeatus L
  • meadowsweet Filipendula ulmaria L
  • orthosiphon Orthosiphon stamincus benth
  • birch Bertula alba
  • cecropia and argan tree Ginkgo biloba, horsetail, escin, cangzhu, Chrysanthellum indicum, Dioscorea plants rich in diosgenin or pure diosgenin or hecogenin and compounds thereof, Ballota, Guioa, Dqvallia, Tenninalia, Bcirringlonia, Trenia, Antirobia, bitter orange (Citrus auramium); and an extract of cocoa bean shells (Theobroina cacao) such as sold under the name Caobromine ® by Solabia.
  • the, personal care composition may comprise from about 0.0001 %, 0.001 %, 0.01 %, 0.05%, 0.1 %, 0.5%, or 1 % to about 30%, 25%, 20%, 10%, 7%, 5%, or 3%, by weight of the composition, of one or more anti-cellulite agents.
  • a desquamation active may be added to the compositions of the present invention.
  • the composition may comprise from about 0.0001 %, 0.001 %, 0.01 %, 0.05%, 0.1 %, 0.5%, or 1 % to about 30%, 25%, 20%, 10%, 7%, 5%, or 3%, by weight of the composition, of one or more desquamation actives.
  • Suitable desquamation actives include beta-hydroxy acids such as salicylic acid and its derivatives (including 5-(noctanoyl)salicylic acid also known as capryloyl salicylic acid) and alpha-hydroxy acids such as glycolic acid, citric acid, lactic acid, tartaric acid, malic acid or mandelic acid; 8-hexadecenc-l, 16-dicarboxylic acid or 9-octadecenedioic acid; urea; gentisic acid; oligofucoses; cinnamic acid; Saphora Japonica extract; and resveratrol.
  • beta-hydroxy acids such as salicylic acid and its derivatives (including 5-(noctanoyl)salicylic acid also known as capryloyl salicylic acid) and alpha-hydroxy acids such as glycolic acid, citric acid, lactic acid, tartaric acid, malic acid or mandelic acid; 8-hexadecenc-l, 16-
  • Suitable desquamation actives include compounds acting on the enzymes involved in desquamating or degrading the comeodesmosomes, glycosidases, stratum corneum chymotryptic enzyme (SCCE) or other proteases (trypsin, chymotrypsin-like).
  • Suitable materials include aminosulphonic compounds such as 4-(2-hydroxyethyl)piperazine-l-propanesulphonic acid (HEPES); 2-oxothiazolidine-4-carboxylic acid (procysteine) and its compounds; compounds of glycine-type alpha-amino acids (as described in U.S. Patent Application Publication No.
  • One desquamation system comprises salicylic acid and zwitterionic surfactants as described in U.S. Patent No. 5,652,228.
  • Another desquamation system contains sulfhydryl compounds and zwitterionic surfactants as described in U.S. Patent No. 5,681 ,852
  • compositions of the present invention can comprise one or more anti-acne actives.
  • Suitable anti-acne actives include, but are not limited to, resorcinol, sulfur, salicylic acid, retinoids such as retinoic acid and its derivatives, sulfur-containing amino acids and their derivatives and salts (e.g. , N-acetyl derivatives such as N-acetyl-L-cysteine), and lipoic acid.
  • suitable anti-acne actives may be chosen from (i) antibiotics and antimicrobials such as benzoyl peroxide, octopirox, tetracycline, 2,4,4'trichloro-2'-hydroxy diphenyl ether, 3,4,4'- trichlorobanilide, azelaic acid and its derivatives, phenoxyethanol, phenoxypropanol, phenoxyisopropanol, ethyl acetate, clindamycin and meclocycline; (ii) sebostats such as flavonoids; and (iii) bile salts such as scymnol sulfate and its derivatives, deoxycholate, and cholate. Further examples of suitable anti-acne actives are described in U. S. Patent No. 5,607,980.
  • the composition may comprise from about 0.0001 %, 0.001 %, 0.01 %, 0.05%, 0.1 %, 0.5%, or 1 % to about 30%, 25%, 20%, 10%, 7%, 5%, or 3 %, by weight of the composition, of one or more anti-acne compounds.
  • compositions of the present invention can include an anti-oxidant/radical scavenger.
  • the composition may comprise from about 0.0001%, 0.001 %, 0.01 %, 0.05%, 0.1 %, 0.5%, or 1 % to about 30%, 25%, 20%, 10%, 7%, 5%, or 3%, by weight of the composition, of one or more anti-oxidant/radical scavengers.
  • Suitable anti-oxidanls are listed in the functional category of "Antioxidants” in the Personal Care Product Council's International Cosmetic Ingredient Dictionary and Handbook, Thirteenth Edition, 2010.
  • Suitable anti-oxidants include butylated hydroxytoluene (BUT) and butylated hydroxyanisole (BHA).
  • BUT butylated hydroxytoluene
  • BHA butylated hydroxyanisole
  • X is OH or SH
  • Y is selected from the group consisting of H, OH, OR5, COOR 5i alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, aromatic, heteroaromatic, carboxamido, sulfonamido, carbamate, urea, and trialkylsilyl;
  • Ri, R2 , R3, R4 are selected from the group consisting of alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, aromatic, heteroaromatic, OR5, carboxamido, sulfonamido, formyl, acyl, carboxyl, carboxylate, carbamate, urea, trialkylsilyl, hydroxy], and hydrogen;
  • R5 is selected from the group consisting of alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, aromatic, heteroaromatic, trialkylsilyl, acyl, and hydrogen.
  • anti-oxidants/radical scavengers such as ascorbic acid (vitamin C), tocopherol
  • vitamin E tocopherol sorbate, tocopherol acetate, other esters of tocopherol, 6-hydroxy-2,5,7,8- tetramethylchroman-2-carboxylic acid (commercially avai lable under the tradename Trolox ⁇ ), amines ⁇ e.g.
  • Suitable anti-oxidants/radical scavengers can be selected from esters of tocopherol such as tocopherol acetate.
  • the composition comprises tocopherol sorbate.
  • tocopherol sorbate As used herein,
  • tocopherol sorbate refers to the sorbic acid ester of tocopherol, a detailed description of which can be found in issued patent US 5,922,758.
  • the composition may comprise from about 0.0001 %, 0.001 %, 0.01 %, 0.05%, 0.1 %, 0.5%, or 1 % to about 50%, 25%, 20%, 10%, 7%, or 5%, by weight of the composition, of the tocopherol sorbate.
  • compositions of the present invention can contain a safe and effective amount of a conditioning agent selected from, for example, humectants, moisturizers, occlusives, and emollients which may be applied to keratinous tissue.
  • a conditioning agent selected from, for example, humectants, moisturizers, occlusives, and emollients which may be applied to keratinous tissue.
  • the composition may comprise from about 0.0001 %, 0.001 %, 0.01 %, 0.05%, 0.1 %, 0.5%, or 1 % to about 50%, 25%, 20%, 10%, 7%, or 5%, by weight of the composition, of one or more conditioning agents.
  • Humectants are one groupd of conditioning agents.
  • Humectants can be selected from the group consisting of poiyhydric alcohols, water soluble alkoxylated nonionic polymers, and mixtures thereof.
  • Poiyhydric alcohols useful herein include glycerin, sorbitol, propylene glycol, butylene glycol, pentylene glycol, hexylene glycol, ethoxylated glucose, 1 , 2-hexane diol, hexanetriol, dipropylene glycol, erythritol, trehalose, diglycerin, xylitol, maltitol, maltose, glucose, fructose, sodium chondroitin sulfate, sodium hyaluronate, hyaluronic acid, sodium adenosine phosphate, sodium lactate, pyrrolidone carbonate, glucosamine, cyclodextrin, and mixtures
  • Water soluble alkoxylated nonionic polymers useful herein include polyethylene glycols and polypropylene glycols having a molecular weight of up to about 1000 such as those with CTFA names PEG-200, PEG -400, PEG-600, PEG- 1000, and mixtures thereof.
  • conditioning agents include, but are not limited to, guanidine, urea, glycolic acid, glycolate salts (e.g. ammonium and quaternary alkyl ammonium), salicylic acid, lactic acid, lactate salts (e.g. , ammonium and quaternary alkyl ammonium), aloe vera in any of its variety of forms (e.g.
  • aloe vera gel polyethylene glycols
  • sugars e.g., melibiose
  • cellulose dextrin
  • starches sugar and starch derivatives (e.g., alkoxylated glucose, fucose)
  • lactamide monoethanolamine e.g., acetamide monoethanolamine
  • panthenol e.g., allantoin, amylose, hyaluronic acid, sodiium hyaluronate, betaglucan, glycogen, alguronic acid, galactoarabinan and mixtures thereof.
  • Extracts that contain polysaccharides include the following: TriMoist MF (Mibelle AG
  • esters are derived from a sugar or polyol moiety and one or more carboxylic acid moieties.
  • Other suitable conditioning agents are described in U.S. Pat. Nos. 5,750, 122; 5,674,478; 4,529,586; 4,507,280; 4,663, 158; 4, 197,865 ; 4,217,914; 4,38 1 ,919: and 4,422, 853.
  • Steroidal anti-inflammatory agents can include, but are not limited to, corticosteroids such as hydrocortisone.
  • nonsteroidal anti-inflammatory agents can be useful herein.
  • the varieties of compounds encompassed by this group are well known to those skilled in the art.
  • Specific non-steroidal anti-inflammatory agents that can be useful in the composition of the present invention include, but are not limited to, salicylates, flufenamic acid, etofenamate, aspirin, and mixtures thereof.
  • Additional anti-inflammatory agents useful herein include allantoin and compounds of the Licorice (the plant genus/species Glycyrrhiza glabra) family, including glycyrrhetic acid, glycyrrhizic acid, and derivat ives thereof (e.g. , salts and esters).
  • Licorice the plant genus/species Glycyrrhiza glabra
  • derivat ives thereof e.g. , salts and esters.
  • the composition may comprises from about 0.0001 %, 0.001 %, 0.01 %, 0.05%, 0.1 %, 0.5%, or 1 % to about 50%, 25%, 20%, 1 0%, 7%, or 5%, by weight of the composition, of one or more anti-inflammatory agents.
  • compositions of the present invention can comprise a tanning active.
  • the composition may comprises from about 0.0001 %, 0.001 %, 0.01 %, 0.05%, 0. 1 %, 0.5%, or 1 % to about 50%, 25%, 20%, 10%, 7%, or 5%, by weight of the composition, of a tanning aciive.
  • a suitable tanning active is dihydroxyacetone.
  • compositions of the present invention can comprise a skin lightening agent.
  • the composition may comprises from about 0.0001 %, 0.001 %, 0.01 %, 0.05%, 0.1 %, 0.5%, or 1% to about 50%, 25%, 20%, 10%, 7%, or 5%, by weight of the composition, of one or more skin lightening agents.
  • Suitable skin lightening agents include those known in the art, including ascorbyl glucoside, kojic acid, hydroquinone arbutin, and tranexamic acid.
  • Other skin lightening materials suitable for use herein can include Acitwhite® (Cognis), Emblica ® (Rona), Azeloglicina (Sinerga) and extracts (e.g.
  • An exemplary skin lightening agent is ascorbyl glucoside.
  • Other skin lightening actives include Phlorogine and Phlorgine BG (laminaria saccharina extract), deoxyarbutin, sucrose dilaurate, bakuchiol, pyrenoine, millet, arlatone dioic acid, cinnamic acid, ferulic acid, achromaxyl, methyl nicotinamide, oil soluble licorice extract, folic acid, undecylenic acid, zinc undecylenate, L- tryptophan, thiamine HQ, hexylresorcinol, lipidami red vine, dragosine, methyl gentisate, inositol, 1 ,2-hexandiol and 1 ,2-octandiol (available as Symdiol 68 from Symrise), laminaine, their salts, their derivatives, their precursors, and
  • the personal care composition may comprise botanical extracts.
  • the composition may comprises from about 0.0001 %, 0.0005% 0.001 %, 0.01 %, 0.05%, 0.1 %, 0.5%, or 1 % to about 30%, 25%, 20%, 10%, 7%, 5%, 3%, by weight of the composition, of one or more botanical extracts.
  • Suitable botanical extracts include extracts from plants (herbs, roots, flowers, fruits, seeds) such as flowers, fruits, vegetables, and so on, including yeast ferment extract, Padina Pavonica extract, thermus thermophilis ferment extract, camelina sativa seed oil, boswellia serrata extract, olive extract,bodopsis Thaliana extract, Acacia Dealbata extract, Acer Saccharinum (sugar maple), acidopholus, acorus, aesculus, Alicaligenes polysaccharides, agaricus, agave, agrimonia, algae, aloe, citrus, brassica, cinnamon, orange, apple, blueberry, cranberry, peach, pear, lemon, lime, pea, seaweed, caffeine, green tea, chamomile, willowbark, mulberry, poppy, and the like.
  • yeast ferment extract including yeast ferment extract, Padina Pavonica extract, thermus thermophilis ferment extract, camelina sativa seed oil, boswelli
  • Glycyrrhiza Glabra Salix Nigra, Macrocycstis Pyrifera, Pyrus Malus, Saxifraga Sarmentosa, Vitis Vinifera, Morus Nigra, Scutellaria Baicalensis, Anthemis Nobilis, Salvia Sclarea, Rosmarinus Officianalis, Citrus Medica Limonum, Ginkgo Biloba Panax Ginseng, Siegesbeckia Orientalis, Fructus ume, Ascophyllum Nodosum, Bifida Ferment lysate, Glycine Soja extract, Beta Vulgaris, Haberlea Rhodopensis, Polygonum Cuspidatum, Citrus Aurantium Dulcis, Vitis Vinifera, Selaginella Tamariscina, Humulus Lupulus, Citrus Reticulata Peel, Punica Granatum, Asparagopsis, Curcuma Longa, Menyanthes Trifoliata
  • the personal care compositions can comprise an antimicrobial or antifungal active.
  • a safe and effective amount of an antimicrobial or antifungal active can be added to the present compositions.
  • the composition may comprises from about 0.0001 %, 0.001 %, 0.01 %, 0.05%, 0. 1 %, 0.5%, or 1 % to about 30%, 25%, 20%, 10%, 7%, 5%, or 3%, by weight of the composition, of one or more antimicrobial, antibacterialand/or antifungal actives.
  • Suitable actives useful herein include those selected from the group consisting of benzoyl peroxide, 3-hydroxy benzoic acid, glycolic acid, lactic acid, 4-hydroxy benzoic acid, 2- hydroxybutanoic acid, 2-hydroxypentanoic acid, 2-hydroxyhexanoic acid, phytic acid, lipoic acid, azelaic acid, arachidonic acid, benzoylperoxide, tetracycline, ibuprofen, naproxen, hydrocortisone, acetominophen, resorcinol, phenoxyethanol, phenoxypropanol, phenoxyisopropanol, lidocaine hydrochloride, neocycin sulfate, and mixtures thereof.
  • Suitable antimicrobial actives include coal tar, sul fur, Whitfield's ointment, castellani' s paint, aluminum chloride, gentian violet, octopirox (piroctone olamine), 2,4,4'-trichloro-2'- hydroxy diphenyl ether (Triclosan),3,4,4'-trichlorocarbanilide (Triclocarban), ciclopirox olamine, imdecylenic acid and metal salts, potassium permanganate, selenium sulfide, sodium thiosulfate, propylene glycol, oil of bitter orange, urea preparations, griseofulvin, 8- Hydroxyquinoline ciloquinol, thiobendazole, thiocarbamates, haloprogin, polyenes, hydroxypyridone, morpholine, benzylamine, allylamines (such as terbinal ' ine), tea tree oil, clove leaf oil, cor
  • Azole antimicrobials may be used and include imidazoles such as benzimidazole, benzothiazole, bifonazole, butaconazole nitrate, climbazole, clotrimazole, croconazole, eberconazole, econazole, elubiol, fenticonazole, fluconazole, f ' lutimazole, isoconazole, ketoconazole, lanoconazole, metronidazole, miconazole, neticonazole, omoconazole, oxiconazole nitrate, sertaconazole, sulconazole nitrate, tioconazole, thiazole, and triazoles such as terconazole and itraconazole, and combinations thereof.
  • imidazoles such as benzimidazole, benzothiazole, bifonazole, butaconazole nitrate, climbazole
  • Selenium sulfide may be used as an antimicrobial.
  • Average particle diameters for the selenium sulfide are typically less than 15 ⁇ , as measured by forward laser light scattering device (e.g. , Malvern 3600 instrument), or, alternately, less than 10 ⁇ .
  • Selenium sulfide compounds are described, for example, in U.S. Pat. No. 2,694,668, 3, 152,046, 4,089,945, and 4,885, 107.
  • Antiperspirant actives may also be included in the compositions of the present invention.
  • Suitable ant iperspirant actives include astringent metallic salts, especially the inorganic and organic salts of aluminum zirconium and zinc, as well as mixtures thereof.
  • Exemplary actives include aluminum containing and/or zirconium-containing materials or salts, such as aluminum halides, aluminum chlorohydrate, aluminum hydroxyhalides, zirconyl oxyhalides, zirconyl hydroxyhalides, and mixtures thereof.
  • the composition may comprises from about 0.0001 %, 0.001 %, 0.01 %, 0.05%, 0.1 %, 0.5%, or 1 % to about 30%, 25%, 20%, 10%, 7%, 5%,, or 3% by weight of the composition, of one or more antiperspirant compounds.
  • the personal care composition may include a warming sensates and/or cooling senate.
  • Sensates provide the sensation of heating or cooling to a user, but may or may not yield a change in skin temperature. The sensation may be instantaneous or may be delayed, but, generally, is appreciable within 5 minutes of application of the skin care composition.
  • the composition may comprises from about 0.0001 %, 0.001 %, 0.01 %, 0.05%, 0. 1 %, 0.5%, or 1 % to about 30%, 25%, 20%, 10%, 7%, 5%, or 3%, by weight of the composition, of one or more sensates. Any mixture of the warming and/or cooling sensates may also be used.
  • Suitable warming sensates include vanillyl alcohol derivatives including of vanillyl alcohol n-butyl ether, vanillyl alcohol n-propyl ether, vanillyl alcohol isopropyl ether, vanillyl alcohol isobutyl ether, vanillyl alcohol n-amino ether, vanillyl alcohol isoamyl ether, vanillyl alcohol n-hexyl ether, vanillyl alcohol methyl ether and vanillyl alcohol ethyl ether; and phosphate derivatives comprising the aforementioned vanillyl alcohol derivatives such as vanillyl alcohol isoamyl ether monophosphate, vanillyl alcohol n-butyl ether monophosphate, vanillyl alcohol n-hexyl ether monophosphate.
  • warming sensates include ethyl alcohol, niacin, jambu, nicotinic acid, zingerone, vanillyl alcohol n-butyl ether, vanillyl alcohol n-propyl ether, vanillyl alcohol isopropyl ether, vanillyl alcohol isobutyl ether, vanillyl alcohol n-amino ether, vanillyl alcohol isoamyl ether, vanillyl alcohol n-hexyl ether-, vanillyl alcohol methyl ether, vanillyl alcohol ethyl ether, gingerol, methyl salicylate, shogaol paradol, zingerone, capsaicin, dihydrocapsaicin, nordihydrocapsaicin, homocapsaicin, homodihydrocapsaicin, ethanol, tincture capsicum, oleoresin ginger alcohol extraction, eucalyptus oil, capsaicin
  • warming sensates include fluid extracts, hydro-alcohol extracts, essential oils, oleoresins, concretes or distillates of mustard seed, ginger, horseradish, chillies, jalapeno, pepper, capsicum, clove, cassia, and mixtures thereof.
  • Suitable cooling sensates include menthol, isopulegole, 3-( l-menthoxy)propan- l ,2-diol, p-menthan-3,8-diol, 6-isopropyl-9-methyl- l ,4-dioxaspiro-(4,5)-decane-2-methanol, menthyl succinate, alkaline earth salts of menthyl succinate, trimethyl cyclohexanol, N-ethyl-2-isopropyl- 5-methylcyclohexane carboxamide and other carboxamic!es as described in U.S. Patent No.
  • menthyl lactate 2-(5'-methyl-2 -(methylethyl)cyclohexyloxy)ethan- l-ol, 3-(5'-methyl-2'-(methylethyl)cyclohexyloxy)piOpan- l -ol, 4-(5'-methyl-2'-(methylethyl) cyclohexyloxy) butan- l -ol, and spearmint.
  • cooling sensates include p-menth-3-yl n-butyl sulphoxide, n-butyl 1 -isobutylcyclohexyl sulphoxide, n-hexyl 1-isobutylcyclohexyl sulphoxide, n-butyl 1 -isoamylcyclohexyl sulphoxide and n-hexyl 1 ,2-diethylcyclohexyl sulphoxide, and other cyclic sulphoxides and sulphones as described in U.S. Patent No. 4,032,661.
  • the composition may comprises from about 0.0001 %, 0.001 %, 0.01 %, 0.05%, 0.1 %, 0.5%, or 1 % to about 10%, 7%, 5%, 2%, or 1 %, by weight of the composition, of one or more preservatives.
  • preservatives are suitable, including such as benzoic acid, benzyl alcohol, benzylhemiformal, benzylparaben, 5-bromo-5- nitro- 1 ,3- dioxane, 2-bromo-2-nitropropane- 1 ,3-diol, butyl paraben, phenoxyethanol, methyl paraben, propyl paraben, diazolidinyl urea, sodium benzoate, calcium benzoate, calcium propionate, caprylyl glycol, biguanide derivatives, phenoxyethanol, captan, chlorhexidine diacetate, chlorhexidine digluconate, chlorhexidine dihydrochloride, chloroacetamide, chlorobutanol, p- chloro-m- cresol, chlorophene, chlorothymol, chloroxylenol, m-cresol, o-cresol, DEDM hydantoin, DEDM hydantoin dio
  • the personal care compositions of the present invention may also contain an anti- dandruff agent.
  • the personal care composition may comprises from about 0.0001 %, 0.001 %, 0.01 %, 0.05%, 0.1 %, 0.5%, or 1 % to about 20%, 10%, 7%, 5%, 4%, 3%, or 2%, by weight of the composition, of one or more anti-dandruff actives.
  • anti-dandruff particulates include: pyridinethione salts, azoles, selenium sulfide, particulate sulfur, and mixtures thereof.
  • pyridinethione anti-dandruff particulates especially l -hydroxy-2-pyridinethione salts
  • Suitable pyridinethione salts include those formed from heavy metals such as zinc, tin, cadmium, magnesium, aluminum and zirconium.
  • zinc or a zinc salt of l-hydroxy-2-pyridinethione (known as "zinc pyridinethione" or "ZPT") may be used
  • l -hydroxy-2-pyridinethione salts may be in platelet particle form, wherein the particles have an average size of up to about 20 ⁇ , up to about 5 ⁇ , or up to about 2.5 ⁇ . Salts formed from other cations, such as sodium, may also be suitable.
  • Pyridinethione anti-dandruff agents are described, for example, in U.S. Pat. Nos. 2,809,971 ; 3,236,733; 3,753, 196; 3,761 ,418; 4,345,080; 4,323,683; 4,379,753; and 4,470,982. It is contemplated that when ZPT is used as the anti-dandruff particulate in the compositions herein, that the growth or re-growth of hair may be stimulated or regulated, or both, or that hair loss may be reduced or inhibited, or that hair may appear thicker or fuller.
  • the personal care composition can comprise one or more substantivity polymers. These polymers may be used to enhance the deposition and longevity of other ingredients onto the keratinous tissue. These polymers may also improve rub-off resistance and water repellence.
  • the composition may comprises from about 0.0001 %, 0.001 %, 0.01 %, 0.05%, 0. 1 %, 0.5%, or 1 % to about 30%, 25%, 20%, 10%, 7%, 5%, or 3%, by weight of the composition, of one or more substantivity polymer.
  • Suitable cationic polymers for use in the .compositions of the present invention contain cationic nitrogen-containing moieties such as quaternary ammonium or cationic protonated amino moieties.
  • the cationic protonated amines can be primary, secondary, or tertiary amines (preferably secondary or tertiary), depending upon the particular species and the selected pH of the composition.
  • Any anionic counlerions can be used in association with the cationic polymers so long as the polymers remain soluble in water, in the composition, or in a coacervate phase of the composition, and so long as the counlerions are physically and chemically compatible with the essential components of the composition or do not otherwise unduly impair product performance, stability or aesthetics.
  • Non limiting examples of such counterions include halides (e.g. , chloride, fluoride, bromide, iodide), sulfate and methylsulfate.
  • Non limiting examples of suitable cationic polymers include copolymers of vinyl monomers having cationic protonated amine or quaternary ammonium functionalities with water soluble spacer monomers such as acrylamide, methacrylamide, alkyl and dialkyl acrylamides, alkyl and dialkyl methacrylamides, alkyl acrylate, alkyl methacrylate, vinyl caprolactone or vinyl pyrrolidone.
  • Suitable cationic protonated amino and quaternary ammonium monomers for inclusion in the cationic polymers of the composition herein, include vinyl compounds substituted with dialkylaminoalkyl acrylate, dialkylaminoalkyl methacrylate, monoalkylaminoalkyl acrylate, monoalkylaminoalkyl methacrylate, trialkyl methacryloxyalkyl ammonium salt, trialkyl acryloxyalkyl ammonium salt, diallyl quaternary ammonium salts, and vinyl quaternary ammonium monomers having cyclic cationic nitrogen-containing rings such as pyridinium, imidazolium, and quaternized pyrrolidone, e.g. , alkyl vinyl imidazolium, alkyl vinyl pyridinium, alkyl vinyl pyrrolidone salts.
  • Suitable cationic polymers for use in the compositions include copolymers of 1 - vinyl-2-pyrrolidone and l-vinyl-3-methylimidazolium salt (e.g. , chloride salt) (INCI name: Polyquaternium- 16); copolymers of l -vinyl-2-pyrrolidone and dimethylaminoethyl methacrylate (INCI name: Polyquatemium- 1 1 ); cationic diallyl quaternary ammonium-containing polymers, including, for example, dimethyldiallylammonium chloride homopolymer, copolymers of acrylamide and dimethyldiallylammonium chloride (INCI name: Polyquatemium 6 and Polyquatemium 7, respectively); amphoteric copolymers of acrylic acid including copolymers of acrylic acid and dimethyldiallylammonium chloride (INCI name: Polyquatemium 22), terpolymers of acrylic acid with dimethyldiallylammonium chloride and acryl
  • R 1 is hydrogen, methyl or ethyl
  • each of R 2 , R 3 and R 4 are independently hydrogen or a short chain alkyl having from about 1 to about 8 carbon atoms
  • n is an integer having a value of from about 1 to about 8
  • X is a counterion.
  • the nitrogen attached to R 2 , R 3 and R 4 may be a protonated amine (primary, secondary or tertiary), but is preferably a quaternary ammonium wherein each of R 2 , R 3 and R 4 are alkyl groups a non limiting example of which is polymethyacrylamidopropyl trimonium chloride, available under the trade name Polycare 133, from Rhone-Poulenc.
  • Suitable cationic polymers for use in the composition include polysaccharide polymers, such as cationic cellulose derivatives and cationic starch derivatives.
  • Suitable cationic polysaccharide polymers include those which conform to the formula:
  • A is an anhydroglucose residual group, such as a starch or cellulose anhydroglucose residual
  • R is an alkylene oxyalkylene, polyoxyalkylene, or hydroxyalkylene group, or combination thereof
  • Rl , R2, and R3 independently are alkyl, aryl, alkylaryl, arylalkyl, alkoxyalkyl, or alkoxyaryl groups, each group containing up to about 18 carbon atoms
  • X is an anionic counterion as described in hereinbefore.
  • Suitable cationic cellulose polymers are salts of hydfoxyethyl cellulose reacted with trimethyl ammonium substituted epoxide, 1NCI name "Polyquaternium 10" and available from Amerchol Corp. (Edison, N.J., USA) in their Polymer LR, JR, and KG series of polymers.
  • Other suitable types of cationic cellulose includes the polymeric quaternary ammonium salts of hydroxyethyl cellulose reacted with lauryl dimethyl ammonium-substituted epoxide, INCI name "Polyquaternium 24.” These materials are available from Amerchol Corp. under the tradename Polymer LM-200.
  • Suitable cationic polymers include cationic guar gum derivatives, such as guar hydroxypropyltrimonium chloride, specific examples of which include the Jaguar series commercially avaialable from Rhone-Poulenc incorporated and the N-Hance series commercially available from Aqualon Division of Hercules, Inc.
  • Other suitable cationic polymers include quaternary nitrogen-containing cellulose ethers, some examples of which are described in U.S. Pat. No. 3,962,41 8.
  • Other suitable cationic polymers include copolymers of etherified cellulose, guar and starch, some examples of which are described in U.S. Pat. No. 3,958,581.
  • compositions herein can comprise nonionic polymers.
  • polyalkylene glycols having a molecular weight of more than about 1000 can be used. These can include those having the following general formula:
  • H(OCH 2 CRH) neat-OH wherein R is selected from the group consisting of H, methyl, and mixtures thereof; and n is a value selected such that the molecular weight of the molecule is greater than 1000 Da.
  • Preferred polyethylene glycol polymers can- include PEG-2M (also known as Polyox WSR® N-10, which is available from Dow Chemical Co.
  • PEG-5M also known as Polyox WSR® N-35 and Polyox WSR ® N-80, available from Dow and as PEG-5,000 and Polyethylene Glycol 300,000
  • PEG-7M also known as Polyox WSR® N-750 available from Dow
  • PEG-9M also known as Polyox WSR ® N-3333 available from Dow
  • PEG- 14 M also known as Polyox WSR ® N-3000 available from Dow.
  • Suitable commercially available substantivity polymers include: Cosmedia DC (hydrogenated dimer Dilinoleyl/ Dimethylcarbonate Copolymer) available from Cognis; Polycrylene (copolymer of adipic acid and neopentyl glycol end-capped with either octyldodecanol or a cyanodiphenylpropenoyl group).
  • Polycrylene has the INCI name Polyester-8 and is available from l lallstar Co; Dow Corning FA 4001 CM Silicone Acrylate and Dow Corning FA 4002 ID Silicone Acrylate (copolymer of polytrimethylsiloxymethacrylate and one or more monomers consisting of acrylic acid, methacrylic acid, or one of their simple esters dissolved in cyclopentasiloxane or isododecane, respectively); Ganex P-904 (poly(butylated vinylpyrrolidone)), Ganex V-216 (vinylpyrrolidone and hexadecene copolymer), Ganex V-220 (vinylpyrrolidone and eicosene copolymer), and Ganex WP-660 (vinyl pyrrolidone and 1- triacontane copolymer), all available from International Specialty Products; Phospholipon 90H (hydrogenated lecithin) available from Phospholipid GmbH; Dermacryl
  • the personal care composition may include one or more detersive surfactants.
  • ther personal care composition may be in the form of a leave-on product that may be substantially free of cleansing or detersive surfactants.
  • leave-on compositions may comprise less than 1 % cleansing surfactants, less than 0.5% cleansing surfactants, or 0% cleansing surfactants
  • the detersive surfactant component can be included to provide cleaning performance to the composition.
  • the detersive surfactant component in turn can comprise anionic detersive surfactant, zwitterionic or amphoteric detersive surfactant, or a combination thereof.
  • Such surfactants should be physically and chemically compatible with the essential components described herein, or should not otherwise unduly impair product stability, aesthetics or performance.
  • Suitable anionic detersive surfactant components for use in the composition herein include those which are known for use in hair care or other personal care cleansing compositions.
  • the concentration of the anionic surfactant component in the composition can preferably be sufficient to provide the desired cleaning and lather performance, which generally can range from about 1 %, 2.5%, 5%, 7.5%, 10%, 12.5%, or 15% to about 50%, 40%, 30%, 25%, 20%, or 10%, by weight of the composition.
  • Suitable anionic surfactants suitable for use in the compositions are the alkyl and alkyl ether sulfates. These materials have the respective formulae ROSO3 and RO(C2H40) x S03M, wherein R is alkyl or alkenyl of from about 8 to about 18 carbon atoms, x is an integer having a value of from 1 to 10, and is a cation such as ammonium, alkanolamines, such as triethanolamine, monovalent metals, such as sodium and potassium, and polyvalent metal cations, such as magnesium, and calcium.
  • R has from about 8 to about 18 carbon atoms, from about 10 to about 16 carbon atoms, or from about 12 to about 14 carbon atoms, in both the alkyl and alkyl ether sulfates.
  • the alkyl ether sulfates are typically made as condensation products of ethylene oxide and monohydric alcohols having from about 8 to about 24 carbon atoms.
  • the alcohols can be synthetic or they can be derived from fats, e.g., coconut oil, palm kernel oil, tallow. Lauryl alcohol and straight chain alcohols derived from coconut oil or palm kernel oil are preferred.
  • Such alcohols are reacted with between about 0 and about 10, from about 2 to about 5, or about 3, molar proportions of ethylene oxide, and the resulting mixture of molecular species having, for example, an average of 3 moles of ethylene oxide per mole of alcohol, is sulfated and neutralized.
  • Suitable anionic detersive surfactants are the water-soluble salts of organic, sulfuric acid reaction products conforming to the formula [ R I -SO3-M ] where R ⁇ is a straight or branched chain, saturated, aliphatic hydrocarbon radical having from about 8 to about 24 or from about 10 to about 18 carbon atoms; and M is a cation described hereinbefore.
  • anionic detersive surfactants are the reaction products of fatty acids esterified with isethionic acid and neutralized with sodium hydroxide where, for example, the fatty acids are derived from coconut oil or palm kernel oil; sodium or potassi um salts of fatty acid amides of methyl tauride in which the fatty acids, for example, are derived from coconut oil or palm kernel oil.
  • Other similar anionic surfactants are described in U.S. Pat. Nos. 2,486,921 , 2,486,922, and 2,396,278.
  • anionic detersive surfactants suitable for use in the compositions are the succinnates, examples of which include disodium N-octadecylsulfosuccinnate; disodium lauryl sulfosuccinate; diammonium lauryl sulfosuccinate; tetrasodium N-( l ,2-dicarboxyethyl)-N- octadecylsul fosuccinnate; diamyl ester of sodium sulfosuccinic acid; dihexyl ester of sodium sull succinic acid; and dioctyl esters of sodium sulfosuccinic acid.
  • succinnates examples of which include disodium N-octadecylsulfosuccinnate; disodium lauryl sulfosuccinate; diammonium lauryl sulfosuccinate; tetrasodium N-( l ,2-dica
  • Suitable anionic detersive surfactants include olefin sulfonates having about 10 to about 24 carbon atoms.
  • the olefin sulfonates can contain minor amounts of other materials, such as alkene disul onates depending upon the reaction conditions, proportion of reactants, the nature of the starting olefins and impurities in the olefin stock and side reactions during the sulfonation process.
  • alpha-olefin sulfonate mixture is described in U.S. Patent 3,332,880.
  • Another class of anionic detersive surfactants suitable for use in the personal care composition is beta-alkyloxy alkane sulfonates. These surfactants conform to the formula
  • P is a straight chain alkyl group having from about 6 to about 20 carbon atoms
  • R2 IS a lower alkyl group having from about 1 to about 3 carbon atoms, preferably 1 carbon atom
  • M is a water-soluble cation as described hereinbefore.
  • Suitable anionic detersive surfactants for use in the compositions include ammonium lauryl sulfate, ammonium laureth sulfate, triethylamine lauryl sulfate, triethylamine laureth sulfate, triethanolamine lauryl sulfate, triethanolamine laureth sulfate, monoethanolamine lauryl sulfate, monoethanolamine laureth sulfate, diethanolamine lauryl sulfate, diethanolamine laureth sulfate, lauric monoglyceride sodium sulfate, sodium lauryl sulfate, sodium laureth sulfate, potassium lauryl sulfate, potassium laureth sulfate, sodium lauryl sarcosinate, sodium lauroyl sarcosinale, lauryl sarcosine, cocoyl sarcosine, ammonium cocoyl sulfate,
  • Suitable amphoteric or zwitterionic detersive surfactants for use in the composition herein include those which are known for use in hair care or other personal care cleansing.
  • Amphoteric detersive sui factants suitable for use in the composition arc well known in the art, and include those surfactants broadly described as derivatives of aliphatic secondary and tertiary amines in which the aliphatic radical can be straight or branched chain and wherein one of the aliphatic substituents contains from about 8 to about 18 carbon atoms and one contains an anionic group such as carboxy, sulfonate, sulfate, phosphate, or phosphonale.
  • Preferred amphoteric detersive surfactants for use in the present invention include cocoamphoacetate, cocoamphodiacetate, lauroamphoacetate, lauroamphodiacetate, and mixtures thereof.
  • suitable zwitterionic or amphoteric surfactants are described in U.S. Pat. Nos. 5, 104,646 and 5, 106,609.
  • Zwitterionic detersive suifactants suitable for use i n the composition are well known in the art, and include those suifactants broadly described as derivatives of aliphatic quaternary ammonium, phosphonium, and sulfonium compounds, in which the aliphatic radicals can be straight or branched chain, and wherein one of the aliphatic substituents contains from about 8 to about 18 carbon atoms and one contains an anionic group such as carboxy, sulfonate, sulfate, phosphate or phosphonate. Zwitterionics such as betaines are preferred.
  • Suitable optional suifactants include nonionic and cationic surfactants. Any such surfactant known in the art for use in hair or personal care products may be used, provided that the optional additional surfactant is also chemically and physically compatible with the essential components of the composition, or does not otherwise unduly impair product performance, aesthetics or stability.
  • non limiting examples of other anionic, zwitterionic, amphoteric or optional additional surfactants suitable for use in the compositions are described in McCutcheon's, Emulsifiers and Detergents, 2010 Annual Ed., published by M. C. Publishing Co., and U.S. Pat. Nos. 3,929,678, 2,658,072, 2,438,091 , and 2,528,378.
  • any other suitable optional component can also be included in the personal care composition of the present invention, such as those ingredients that are conventionally used in given product types.
  • iodopropyl butylcarbamate antifungal agents, antioxidants, binders, buffering agents, bulking agents, chelating agents, colorants, cosmetic astringents, cosmetic biocides, denaturants, drug astringents, external analgesics, film formers, opacifying agents, pH adjusters, plant derivatives, plant extracts, plant tissue extracts, plant seed extracts, plant oils, botanicals, botanical extracts, preservatives, propellants, reducing agents, sebum control agents, sequestrants, skin bleaching agents, skin- conditioning agents (e.g. humectants and occlusive agents), and skin protec.torants.
  • Other suitable optional person care ingredients include materials listed in paragraphs 513-839 of U.S Patent Application No. 2010/01 12100.
  • Cyclomelhicone 1 1.4 23.5 15 10.0 1.05 1.05
  • Glycerin 10.0 10.0 1 1 1 1 10 10.0 2.0 10.0 2.0
  • Tocopherol Acetate 0.50 0.2 0.2 0.5 0.5 0.5 0.5 ⁇ 0.5
  • exemplary pl l tunable gellants for basic or neutral examples include /V,/V'-(2S,2'S)-
  • Exemplary pl l tunable gellants for acidic examples include (65, 14S 6, 14-diisopropyl-4,7, 13,16-lctraoxo-5,8, 12, 15-tetraazanonadecaiie-l ,19-dioic acid and (65,23S)-6,23- diisopr()pyl-4,7,22,25-tetraoxo-5,8.21 ,24-tetraazaoctacosane-l ,28-dioic acid.
  • the pH tunable gellant amounts may be from about 0.01 % to about 3%.
  • Phase A combine the ingredients of Phase A in a suitable container.
  • Phase B combine the ingredients of Phase B .
  • a suitable mixer e.g. , Anchor blade, propeller blade
  • the ingredients are combined and mixed (wilh heat if needed) until uniform; the composition may be warmed to dissolve all ingredients. Once the composition is uniform, the product is poured into suitable containers.
  • the pH tuneable gellant may be via a premix containing the designed amount of gellant and suitable amount of carrier fluid from the phase to be structured.
  • the personal care compositions of the present invention are useful for improving or regulating a number of keratinous tissue conditions.
  • "regulating" means maintaining skin appearance and/or feel of the keratinous tissue with little to no degradation in appearance and/or feel
  • “improving” means affecting a positive change in keratinous tissue appearance and/or feel.
  • the keratinous tissue appearance and/or feel benefit may be an acute or chronic benefit.
  • Keratinous tissue conditions that may be regulated or improved include, but are not limited to thickening keratinous tissue (e.g. , building the epidermis and/or dermis and/or subcutaneous layers of the skin or lips and where applicable the keratinous layers of the nail and hair shaft including eye lashes), atrophy, softening and/or smoothing, itch, appearance of dark under-eye ci rcles and/or puffy eyes, sallowness, sagging (e.g.
  • glycation tanning
  • desquamating desquamating
  • exfoliating and/or increasing turnover in mammalian skin
  • pores size pores size
  • oily/shiny appearance hyperpigmentation
  • hyperpigmentation such as post-inflammatory hyperpigmentation
  • spider vessels and/or red blotchiness on mammalian skin
  • fine lines and wrinkles dryness (e.g., roughness, scaling, flaking), cellulite, and acne.
  • keratinous conditions that may be regulated or improved include signs of skin aging including, but not limited to, all outward visibly and tactilely perceptible manifestations, as well as any macro- or micro-effects, due to keratinous tissue aging. These signs may result from processes which include, but are not limited to, the development of textural discontinuities such as wrinkles and coarse deep wrinkles, fine lines, skin lines, crevices, bumps, large pores, unevenness or roughness; loss of skin elasticity; discoloration (including undereye circles); blotchiness; sallowness; hyperpigmented skin regions such as age spots and freckles; keratoses; abnormal differentiation; hyperkeratinization; elastosis; collagen breakdown, and other histological changes in the stratum corneum, dermis, epidermis, vascular system (e.g.
  • insult-affected keratinous tissue means keratinous tissue which exhibits discomfort, irritation, an unpleasant or irregular appearance, and the like, for example after exposure lo a physical and/or chemical irritant.
  • insult-affected keratinous tissue include burn (e.g. , sunburns, windburn, chemical or thermal burns); rashes (e.g.
  • insults include radiation, wind, low humidity, allergens, pollutants, chemical and natural irritants, bodily fluids, bodily waste, excessive moisture, bacteria, fungi, etc.
  • Regulating and improving keratinous tissue condition involves topically applying to the keratinous tissue a safe and effective amount of a composition of the present invention.
  • the amount of the composition that is applied, the frequency of application and the period of use will vary widely depending upon the actives and other components of a given composition and the level of regulation or improvement desired.
  • the composition is chronically applied to the keratinous tissue and, more specifically, the skin.
  • chromenic topical application routine or periodic application of the composition over a time period during the subject's li fetime. Suitable time periods include at least about one week, at least about one month, at least about three months, at least about six months, and at least about one year. Typically applications would be on the order of about once per day over such extended periods, however application rates can vary from about once per week up to about three times per day or more.
  • a wide range of quantities of the compositions of the present invention can be employed to provide a skin appearance and/or feel benefit.
  • Quantities of the present compositions which are typically applied per application, are, in mg of composition per cm ⁇ of keratinous tissue and, more specifically, the skin.
  • a suitable application quantity is from about 0.1 mg/cm ⁇ to about 20 mg/cm ⁇ or from about 0.5 mg/cm ⁇ to about 10 mg/cm ⁇ .
  • Suitable keratinous tissues to which the compositions may be employed include any part of the external portion of the face, hair, and/or nails.
  • the personal care composition may be applied to the face, lips, under-cye area, eyelids, scalp, neck, torso, arms, hands, legs, fingernails, toenails, scalp hair, eyelashes, eyebrows, and the like.
  • the personal care composition is applied to a "facial skin surface," which refers to one or more of the forehead, periorbital, cheek, perioral, chin, and nose skin surfaces.
  • Leave-on composition may be left on the keratinous tissue for a period of at least about 15 minutes, at least about 30 minutes, at least about 1 hour, or for several hours (e.g. , over 12 hours).
  • compositions may be done using, e.g. , the palms of the hands and/or fingers, an implement, e.g., a cotton ball, swab, pad etc.
  • an implement e.g., a cotton ball, swab, pad etc.
  • the composition can be dispensed from a bottle, jar, tube, sachet, pouch, container, bottle, vial, ampoule, compact, etc. or can be integrally contained within a delivery form such as a wipe.
  • the application of the present compositions may be done using the palms of the hands and/or fingers.
  • the application may also be done with the aid of a device or implement such as a cotton ball, swab, pad, brush, eye dropper, puff, sponge, wand, wipe, foam, nonwoven substrate, mask, roll-on applicator, stick applicator, applicator pen, spray applicator, atomizer, razor, etc.
  • the active may be contained in a rupturable pouch between two substrates.
  • NTU Nephelometric Turbidity Units
  • Hach 2100P turbidity meter calibrated according to the procedure provided by the manufacture.
  • the sample vials are filled with 15ml of representative sample and capped and cleaned according to the operating instructions. If necessary, the samples are degassed to remove any bubbles cither by applying a vacuum or using an ultrasonic bath (see operating manual for procedure).
  • the turbidity is measured using the automatic range selection.
  • Viscosity - Viscosities are measured on a Brookfield viscometer using a T-C bar spindle with a heliopath setting at 5 rpm at 25°C
  • Minimum gelling concentration (MGC) - MGC is calculated by a tube inversion method based on R.G. Weiss, P. Terech; "Molecular Gels: Materials with self-assembled fibrillar structures” 2006, Springer, p. 243.
  • MGC Minimum gelling concentration
  • Second screening prepare several vials increasing the pH tuneable gellant concentration in 0. 1 weight % steps in the interval determined in the first screening.
  • MGC Minimum Gelling Concentration
  • samples are prepared and treated as follows: 8mL vials (Borosilacate glass with Teflon cap, rcf. B7857D, Fisher Scientific Bioblock) are filled with 2.0000+0.0005 g (KERN ALJ 120-4 analytical balance with ⁇ 0. 1 mg precision) of the liquid (comprising the liquid detergent composition and pH Tuneable gellant) for which we want to determine the MGC.
  • the vial is sealed with the screw cap and left for 10 minutes in an ultrasound bath (Elma Transsonic T 710 DH, 40 kHz, 9.5L, at 25 °C and operating at 100% power) in order to disperse the solid in the liquid.
  • vapours may be formed, and upon cooling down the samples, these vapours can condense on top of the gel .
  • this condensed vapour will flow. This is discounted during the observation period. If no gels are obtained in the concentration interval, higher concentrations must be evaluated.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
EP12730723.9A 2011-06-13 2012-06-13 Körperpflegezusammensetzungen mit ph-abstimmbarem geliermittel und verwendungsverfahren Withdrawn EP2717967A2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161496312P 2011-06-13 2011-06-13
PCT/US2012/042221 WO2012174091A2 (en) 2011-06-13 2012-06-13 PERSONAL CARE COMPOSITIONS COMPRISING A pH TUNEABLE GELLANT AND METHODS OF USING

Publications (1)

Publication Number Publication Date
EP2717967A2 true EP2717967A2 (de) 2014-04-16

Family

ID=46397631

Family Applications (1)

Application Number Title Priority Date Filing Date
EP12730723.9A Withdrawn EP2717967A2 (de) 2011-06-13 2012-06-13 Körperpflegezusammensetzungen mit ph-abstimmbarem geliermittel und verwendungsverfahren

Country Status (4)

Country Link
EP (1) EP2717967A2 (de)
JP (1) JP2014524900A (de)
CN (1) CN104039396A (de)
WO (1) WO2012174091A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012174096A2 (en) * 2011-06-13 2012-12-20 The Procter & Gamble Company Personal care compositions comprising a di-amido gellant and methods of using
KR101699510B1 (ko) * 2012-07-12 2017-01-24 닛산 가가쿠 고교 가부시키 가이샤 옥심 치환 아미드 화합물 및 유해 생물 방제제
US9744116B2 (en) 2013-09-18 2017-08-29 L'oreal High color intensity and easily removable mascara
CN107454837B (zh) * 2016-09-12 2019-08-20 拉芳家化股份有限公司 一种含头发保湿复合剂的香波组合物
US20220339087A1 (en) * 2021-04-22 2022-10-27 Lume Deodorant, Llc Acidic Stick Deodorants
EP4205727A1 (de) * 2021-12-31 2023-07-05 Sislan (Zhuhai) Pharmaceutical Technology Co., Ltd Deodorant zusammensetzung mit geringer hautreizung, sowie verfahren zu deren herstellung
DE102023201455A1 (de) 2023-02-20 2024-08-22 Ident UG (haftungsbeschränkt) & Co. KG Zusammensetzungen zur Dentalhygiene

Family Cites Families (110)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE406221A (de) 1933-11-15
US2438091A (en) 1943-09-06 1948-03-16 American Cyanamid Co Aspartic acid esters and their preparation
BE498391A (de) 1944-10-16
BE498392A (de) 1945-11-09
US2528378A (en) 1947-09-20 1950-10-31 John J Mccabe Jr Metal salts of substituted quaternary hydroxy cycloimidinic acid metal alcoholates and process for preparation of same
US2658072A (en) 1951-05-17 1953-11-03 Monsanto Chemicals Process of preparing amine sulfonates and products obtained thereof
US2694668A (en) 1952-03-10 1954-11-16 Abbott Lab Liquid multiple vitamin preparation and process of preparing the same
US2809971A (en) 1955-11-22 1957-10-15 Olin Mathieson Heavy-metal derivatives of 1-hydroxy-2-pyridinethiones and method of preparing same
US3152046A (en) 1956-11-09 1964-10-06 Kapral Ales Maria Selenium disulfide dispersions
US3236733A (en) 1963-09-05 1966-02-22 Vanderbilt Co R T Method of combatting dandruff with pyridinethiones metal salts detergent compositions
US3439088A (en) 1964-06-16 1969-04-15 Exxon Research Engineering Co Cosmetic preparations-wax rouge and foundation make-up
US3332880A (en) 1965-01-04 1967-07-25 Procter & Gamble Detergent composition
US3761418A (en) 1967-09-27 1973-09-25 Procter & Gamble Detergent compositions containing particle deposition enhancing agents
US4136163A (en) 1971-02-04 1979-01-23 Wilkinson Sword Limited P-menthane carboxamides having a physiological cooling effect
US3755560A (en) 1971-06-30 1973-08-28 Dow Chemical Co Nongreasy cosmetic lotions
US3818105A (en) 1971-08-23 1974-06-18 Exxon Research Engineering Co Composition and process for lubricating the skin
US3753196A (en) 1971-10-05 1973-08-14 Kulite Semiconductor Products Transducers employing integral protective coatings and supports
GB1421743A (en) 1972-04-18 1976-01-21 Wilkinson Sword Ltd Ingestible topical and other compositions
US3958581A (en) 1972-05-17 1976-05-25 L'oreal Cosmetic composition containing a cationic polymer and divalent metal salt for strengthening the hair
CA1027347A (en) 1972-07-20 1978-03-07 David G. Rowsell Compounds having a physiological cooling effect and compositions containing them
CA1018893A (en) 1972-12-11 1977-10-11 Roger C. Birkofer Mild thickened shampoo compositions with conditioning properties
US4217914A (en) 1974-05-16 1980-08-19 L'oreal Quaternized polymer for use as a cosmetic agent in cosmetic compositions for the hair and skin
US4422853A (en) 1974-05-16 1983-12-27 L'oreal Hair dyeing compositions containing quaternized polymer
DE2437090A1 (de) 1974-08-01 1976-02-19 Hoechst Ag Reinigungsmittel
US4089945A (en) 1975-06-30 1978-05-16 The Procter & Gamble Company Antidandruff shampoos containing metallic cation complex to reduce in-use sulfide odor
AT365448B (de) 1975-07-04 1982-01-11 Oreal Kosmetische zubereitung
US4197865A (en) 1975-07-04 1980-04-15 L'oreal Treating hair with quaternized polymers
US4663158A (en) 1979-07-02 1987-05-05 Clairol Incorporated Hair conditioning composition containing cationic polymer and amphoteric surfactant and method for use
US4507280A (en) 1979-07-02 1985-03-26 Clairol Incorporated Hair conditioning composition and method for use
US4345080A (en) 1980-02-07 1982-08-17 The Procter & Gamble Company Pyridinethione salts and hair care compositions
US4379753A (en) 1980-02-07 1983-04-12 The Procter & Gamble Company Hair care compositions
US4323683A (en) 1980-02-07 1982-04-06 The Procter & Gamble Company Process for making pyridinethione salts
US4529586A (en) 1980-07-11 1985-07-16 Clairol Incorporated Hair conditioning composition and process
US4470982A (en) 1980-12-22 1984-09-11 The Procter & Gamble Company Shampoo compositions
US4421769A (en) 1981-09-29 1983-12-20 The Procter & Gamble Company Skin conditioning composition
US4677120A (en) 1985-07-31 1987-06-30 Molecular Design International Topical prodrugs for treatment of acne and skin diseases
US5143722B1 (en) 1986-12-19 1999-08-24 Revlon Consumer Prod Corp Cosmetic makeup compositions comprising water-in-oil emulsions containing pigment
US4976953A (en) 1987-03-06 1990-12-11 The Procter & Gamble Company Skin conditioning/cleansing compositions containing propoxylated glycerol derivatives
US4885107A (en) 1987-05-08 1989-12-05 The Procter & Gamble Company Shampoo compositions
US4885311A (en) 1987-06-29 1989-12-05 Molecular Design International Topical transretinoids for treatment of acne and skin diseases
US5124356A (en) 1987-06-29 1992-06-23 Molecular Design International, Inc. Dermal uses of trans-retinoids for the treatment of photoaging
USRE34075E (en) 1987-06-29 1992-09-22 Molecular Design International, Inc. Dermal uses of trans-retinoids for the treatment of cancer
US5049584A (en) 1988-12-14 1991-09-17 Molecular Design International Dermal uses of cis-retinoids for the treatment of cancer
JPH0660286B2 (ja) 1989-02-15 1994-08-10 信越化学工業株式会社 油性ペースト組成物
US5106609A (en) 1990-05-01 1992-04-21 The Procter & Gamble Company Vehicle systems for use in cosmetic compositions
US5104646A (en) 1989-08-07 1992-04-14 The Procter & Gamble Company Vehicle systems for use in cosmetic compositions
US5413781A (en) 1991-01-17 1995-05-09 Dow Corning Corporation Alkylmethylsiloxanes for skin care
JP2631772B2 (ja) 1991-02-27 1997-07-16 信越化学工業株式会社 新規なシリコーン重合体及びそれを用いた水分散能を有するペースト状シリコーン組成物
DE4110973A1 (de) 1991-04-05 1992-10-08 Haarmann & Reimer Gmbh Mittel mit physiologischem kuehleffekt und fuer diese mittel geeignete wirksame verbindungen
EP0545002A1 (de) 1991-11-21 1993-06-09 Kose Corporation Siliconpolymer und dieses enthaltende pastöse Zusammensetzung sowie kosmetische Zubereitung des Typs Wasser-in-Öl
FR2691065B1 (fr) 1992-05-18 1994-07-29 Morelle Jean Nouvelles compositions oculaires destinees a la prevention et au traitement de certains troubles de la vision.
FR2699818B1 (fr) 1992-12-24 1995-02-03 Oreal Composition cosmétique ou pharmaceutique contenant en association un polyphénol et un extrait de gingko.
CN1100532C (zh) 1993-11-12 2003-02-05 普罗克特和甘保尔公司 含水杨酸和两性离子化合物的去皮屑组合物
US5681852A (en) 1993-11-12 1997-10-28 The Procter & Gamble Company Desquamation compositions
US5922758A (en) 1994-09-21 1999-07-13 The Procter & Gamble Company Methods and compositions employing 2,4-dienoic acid esters of tocopherols to prevent or reduce skin damage
JPH08217536A (ja) 1995-02-14 1996-08-27 Tdk Corp 正の抵抗温度係数を有する半導体磁器組成物及びその製造方法
US5607980A (en) 1995-07-24 1997-03-04 The Procter & Gamble Company Topical compositions having improved skin feel
US5725845A (en) 1995-11-03 1998-03-10 Revlon Consumer Products Corporation Transfer resistant cosmetic stick compositions with semi-matte finish
US5939082A (en) 1995-11-06 1999-08-17 The Procter & Gamble Company Methods of regulating skin appearance with vitamin B3 compound
US5674478A (en) 1996-01-12 1997-10-07 The Procter & Gamble Company Hair conditioning compositions
US5750122A (en) 1996-01-16 1998-05-12 The Procter & Gamble Company Compositions for treating hair or skin
US5654362A (en) 1996-03-20 1997-08-05 Dow Corning Corporation Silicone oils and solvents thickened by silicone elastomers
US5837793A (en) 1996-03-22 1998-11-17 Dow Corning Toray Silicone Co., Ltd. Silicone rubber powder and method for the preparation thereof
US5760116A (en) 1996-09-05 1998-06-02 General Electric Company Elastomer gels containing volatile, low molecular weight silicones
US5811487A (en) 1996-12-16 1998-09-22 Dow Corning Corporation Thickening silicones with elastomeric silicone polyethers
TW508247B (en) 1997-03-31 2002-11-01 Shiseido Co Ltd Cosmetic or dermatological topical composition
US5997887A (en) 1997-11-10 1999-12-07 The Procter & Gamble Company Skin care compositions and method of improving skin appearance
US6159485A (en) 1999-01-08 2000-12-12 Yugenic Limited Partnership N-acetyl aldosamines, n-acetylamino acids and related n-acetyl compounds and their topical use
FR2791257B1 (fr) 1999-03-22 2001-05-11 Oreal Utilisation comme agent tenseur d'au moins un polymere silicone greffe
US6113931A (en) 1999-03-25 2000-09-05 The C.P. Hall Company Clear formulations containing diesters or polyesters of naphthalene dicarboxylic acid
US6126925A (en) 1999-03-25 2000-10-03 The C. P. Hall Company Photostable sunscreen compositions containing dibenzoylmethane derivative, e.g., PARSOL® 1789, and diesters of naphthalene dicarboxylic acid photostabilizers and enhancers of the sun protection factor (SPF)
US5993789A (en) 1999-03-25 1999-11-30 The C.P. Hall Company Photostable sunscreen compositions containing dibenzoylmethane derivative, E.G., parsol® 1789, and diesters or polyesters of naphthalene dicarboxylic acid photostabilizers and enhancers of the sun protection factor (SPF)
US6696049B2 (en) 2000-07-10 2004-02-24 The Procter & Gamble Company Cosmetic compositions
US6524598B2 (en) 2000-07-10 2003-02-25 The Procter & Gamble Company Cosmetic compositions
US20020182237A1 (en) 2001-03-22 2002-12-05 The Procter & Gamble Company Skin care compositions containing a sugar amine
US6831191B2 (en) 2001-12-20 2004-12-14 Em Industries Photo stable organic sunscreen compounds with antioxidant properties and compositions obtained therefrom
US6602515B2 (en) 2001-07-16 2003-08-05 Em Industries Photo stable organic sunscreen compounds with antioxidant properties and compositions obtained therefrom
US6872401B2 (en) 2002-03-28 2005-03-29 L'oreal Cosmetic/dermatological compositions comprising a tetrahydrocurcuminoid and an amide oil
DE60332012D1 (de) 2002-05-02 2010-05-20 Basf Se Stabilisierte körperpflegemitte und haushaltsprodukte
ATE468104T1 (de) * 2002-06-12 2010-06-15 Oreal Mit silikonpolymeren und organischen geliermitteln strukturierte pflege- und/oder- makeup-zusammensetzung in starrer form
US7879316B2 (en) 2002-06-12 2011-02-01 L'oreal Cosmetic composition containing a polyorganosiloxane polymer
JP4490817B2 (ja) 2002-09-12 2010-06-30 信越化学工業株式会社 新規なオルガノポリシロキサン重合物及びペースト状組成物並びにその組成物を用いた化粧料
US6919473B2 (en) 2002-09-17 2005-07-19 Cph Innovations Corporation Photostabilizers, UV absorbers, and methods of photostabilizing a sunscreen composition
US6926887B2 (en) 2002-09-17 2005-08-09 The C.P. Hall Company Photostabilizers, UV absorbers, and methods of photostabilizing a sunscreen composition
US6800274B2 (en) 2002-09-17 2004-10-05 The C.P. Hall Company Photostabilizers, UV absorbers, and methods of photostabilizing a sunscreen composition
CN1681475B (zh) 2002-09-20 2010-05-26 宝洁公司 包含清洁相和独立有益相的条纹状液体个人清洁组合物
US7285570B2 (en) 2003-04-17 2007-10-23 The Procter & Gamble Company Compositions and methods for regulating mammalian keratinous tissue
KR20090100431A (ko) 2003-05-01 2009-09-23 더 프록터 앤드 갬블 캄파니 시각적으로 구별되는 다중 액상 조성물
GB0403702D0 (en) 2004-02-19 2004-03-24 Boots Co Plc Skincare compositions
US7357919B2 (en) 2004-10-19 2008-04-15 L'oreal Photostable photoprotective compositions comprising dibenzoylmethane and arylalkyl benzoate compounds and a compound that accepts the excited triplet level energy of said dibenzoylmethane(s)
US7854947B2 (en) 2004-12-17 2010-12-21 Akzo Nobel N.V. Personal care compositions comprising plant fiber
US20060147396A1 (en) 2005-01-03 2006-07-06 L'oreal Composition containing ascorbic acid
US20070020220A1 (en) 2005-04-27 2007-01-25 Procter & Gamble Personal care compositions
FR2886143B1 (fr) 2005-05-31 2007-06-29 Oreal Photostabilisation d'un dibenzoylmethane par une s-triazine siliciee et substituee par deux groupes aminobenzoates ou aminobenzamides ; compositions photoprotectrices. nouveaux composes silicies s-triazine
EP1754517A1 (de) 2005-08-17 2007-02-21 The Procter and Gamble Company Faser- und Haarfaserkonditioniermittel
US20070297996A1 (en) 2006-06-22 2007-12-27 The Procter & Gamble Company Multi-phase composition comprising a sunscreen
US20080019930A1 (en) 2006-06-23 2008-01-24 L'oreal Dibenzoylmethane sunscreens photostabilized with arylalkyl amide or ester compounds
FR2910807A1 (fr) * 2006-12-29 2008-07-04 Oreal Composition cosmetique comprenant un derive de bis uree.
GB0703328D0 (en) * 2007-02-21 2007-03-28 Pliva Istrazivanje I Razvoj D Gel forming compounds
JP5347104B2 (ja) * 2007-03-09 2013-11-20 味の素株式会社 ゲル化剤
WO2008110672A1 (fr) 2007-03-12 2008-09-18 L'oreal Utilisation d'un derive c-glycoside a titre d'agent anti-oxydant
GB0705264D0 (en) * 2007-03-20 2007-04-25 Pliva Istrazivanje I Razvoj D Gel forming compounds
US7597825B2 (en) 2007-08-09 2009-10-06 Hallstar Innovations Corp. Method of quenching electronic excitation of chromophore-containing organic molecules in photoactive compositions
FR2939315B1 (fr) 2008-12-08 2011-01-21 Oreal Composition cosmetique contenant un derive de dibenzoylmethane et un compose ester de 2-pyrrolidinone 4-carboxy ; procede de photostabilisation du derive de dibenzoylmethane
US9676696B2 (en) 2009-01-29 2017-06-13 The Procter & Gamble Company Regulation of mammalian keratinous tissue using skin and/or hair care actives
WO2011052613A1 (ja) * 2009-10-26 2011-05-05 日産化学工業株式会社 化粧料及び皮膚外用剤、並びに医療用機器
MX2012010574A (es) * 2010-03-12 2012-10-09 Procter & Gamble Composiciones detergentes liquidas que comprenden gelificantes amido ajustables por ph y los procesos para fabricarlas.
WO2012174096A2 (en) * 2011-06-13 2012-12-20 The Procter & Gamble Company Personal care compositions comprising a di-amido gellant and methods of using
CN104114535B (zh) * 2012-02-09 2016-09-14 味之素株式会社 两性离子型碱性氨基酸衍生物
WO2013118896A1 (ja) * 2012-02-09 2013-08-15 味の素株式会社 塩基性アミノ酸誘導体

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2012174091A2 *

Also Published As

Publication number Publication date
WO2012174091A2 (en) 2012-12-20
JP2014524900A (ja) 2014-09-25
CN104039396A (zh) 2014-09-10
WO2012174091A3 (en) 2014-06-26

Similar Documents

Publication Publication Date Title
US9271912B2 (en) Personal care compositions comprising a pH tuneable gellant and methods of using
US11160734B2 (en) Personal care compositions comprising shaped abrasive particles
WO2012174096A2 (en) Personal care compositions comprising a di-amido gellant and methods of using
EP2717967A2 (de) Körperpflegezusammensetzungen mit ph-abstimmbarem geliermittel und verwendungsverfahren
AU2017374588C1 (en) Method for improving the sensorial properties of oil-in-water emulsions
JP5350402B2 (ja) ホマリン及びエリスリトールの組み合わせを含む保湿用化粧品組成物
ES2301713T3 (es) Preparacion cosmetica que contiene policarbonatos.
JP6092900B2 (ja) Ｕｖ複合体を含む日焼け止め剤組成物
ES2307811T3 (es) Utilizacion de los dioles dimericos.
ES2401935T3 (es) Sistema de emulsionante
JP2009507012A (ja) 毛包脂腺ユニットの活性を調節する活性物質としてのプロトベルベリン（ｐｒｏｔｏｂｅｒｂｅｒｉｎｅ）の使用
BR112019004971B1 (pt) Composições de gel hidratante
MX2007009151A (es) Aditivos para banos corporales.
US20160367091A9 (en) Personal Care Compositions Comprising a Di-Amido Gellant and Methods of Using
ES2309225T3 (es) Emulsiones cosmeticas y/o farmaceuticas.
AU2004233472A1 (en) High lipid content sprayable emulsions
ES2967698T3 (es) Medicamento para el tratamiento del envejecimiento de la piel causado por radiación UV
US9241891B2 (en) Personal care compositions comprising self-assembling peptides
ES2285584T3 (es) Formulaciones fotoprotectoras cosmeticas y dermatologicas con un contenido en filtros uva quimicos y triheptanonina.
JP6899200B2 (ja) 外用組成物、及びそれを用いたメイクアップ用化粧料
WO2024003594A1 (en) Personal care compositions comprising pancratium maritimum
JP2006151901A (ja) 噴霧可能な水中油型乳剤
JP2022051529A (ja) 皮膚外用剤

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20131125

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

R17D Deferred search report published (corrected)

Effective date: 20140626

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20150115